ID

9658

Description

RTOG-0924 F0: Interim Follow-Up Form Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9D96A377-7B59-275E-E040-BB89AD437DB1

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9D96A377-7B59-275E-E040-BB89AD437DB1

Keywords

  1. 9/19/12 9/19/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 1/9/15 1/9/15 - Martin Dugas
  4. 1/9/15 1/9/15 - Martin Dugas
Uploaded on

January 9, 2015

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0 Legacy

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Prostate Cancer NCT01368588 Follow-Up - RTOG-0924 F0: Interim Follow-Up Form - 3197931v1.0

INSTRUCTIONS: Submit this form at the appropriate follow-up interval. All dates to be reported mm-dd-yyyy unless otherwise indicated

Unnamed2
Description

Unnamed2

RTOG Study No.
Description

Protocol ID RTOG

Data type

text

Alias
NCI Thesaurus ValueDomain
C25337
UMLS CUI-1
C3274381
NCI Thesaurus ObjectClass
C25320
UMLS CUI-2
C1514695
NCI Thesaurus Property
C19778
NCI Thesaurus Property-2
C25364
Case #
Description

RadiationTherapyOncologyGroupPatientCaseIdentifierNumber

Data type

text

Alias
NCI Thesaurus ObjectClass
C16960
UMLS 2011AA ObjectClass
C0030705
NCI Thesaurus ObjectClass-2
C19778
UMLS 2011AA ObjectClass-2
C1514695
NCI Thesaurus Property
C25364
UMLS 2011AA Property
C0600091
NCI Thesaurus Property-2
C49152
UMLS 2011AA Property-2
C1706256
NCI Thesaurus ValueDomain
C25337
UMLS 2011AA ValueDomain
C0237753
Institution Name
Description

Institution Name

Data type

text

Alias
NCI Thesaurus ValueDomain
C25191
UMLS CUI-1
C1301943
NCI Thesaurus ObjectClass
C21541
NCI Thesaurus ValueDomain-2
C21541
NCI Thesaurus Property
C25364
Institution No.
Description

Institution Number

Data type

text

Alias
NCI Thesaurus ValueDomain
C25337
UMLS CUI-1
C1301943
NCI Thesaurus ObjectClass
C21541
UMLS CUI-2
C0805701
NCI Thesaurus Property
C25364
Patient Initials
Description

Patient Initials

Data type

text

Alias
NCI Thesaurus ValueDomain
C25191
UMLS CUI-1
C2986440
NCI Thesaurus ObjectClass
C16960
NCI Thesaurus Property
C25536
RTOG Patient ID
Description

Trial subject ID RTOG

Data type

text

Alias
NCI Thesaurus ValueDomain
C25337
UMLS CUI-1
C2348585
NCI Thesaurus ObjectClass
C16960
UMLS CUI-2
C1514695
NCI Thesaurus Property
C19778
NCI Thesaurus Property-2
C25364
Header
Description

Header

Amended Data
Description

Data amended

Data type

boolean

Alias
NCI Thesaurus ValueDomain
C38148
UMLS CUI-1
C0680532
NCI Thesaurus ObjectClass
C25474
NCI Thesaurus Property
C25416
Unnamed 3
Description

Unnamed 3

Patient's Vital Status
Description

Patient Status

Data type

text

Alias
NCI Thesaurus ObjectClass
C16960
UMLS CUI-1
C3846084
NCI Thesaurus ValueDomain
C18003
NCI Thesaurus ValueDomain-2
C25688
NCI Thesaurus Property
C25717
Date of Last Contact or Death
Description

Date last contact

Data type

date

Alias
NCI Thesaurus ObjectClass
C16960
UMLS CUI-1
C0805839
NCI Thesaurus Property
C25461
NCI Thesaurus Property-2
C25551
NCI Thesaurus ValueDomain
C25164
NCI Thesaurus ValueDomain-2
C25367
Primary Cause of Death
Description

Primary Cause of Death

Data type

text

Alias
NCI Thesaurus ValueDomain
C25638
UMLS CUI-1
C0007465
NCI Thesaurus ObjectClass
C16960
NCI Thesaurus Property
C28554
NCI Thesaurus ValueDomain-2
C25251
Due to other cause, specify
Description

Primary Cause of Death, specify

Data type

text

Alias
NCI Thesaurus ObjectClass
C16960
UMLS CUI-1
C0007465
NCI Thesaurus ObjectClass-2
C25251
NCI Metathesaurus ObjectClass
C0007465
NCI Thesaurus Property
C17649
NCI Thesaurus Property-2
C25365
NCI Thesaurus ValueDomain
C25685
Has the patient had a documented clinical assessment for this cancer (SINCE SUBMISSION OF THE PREVIOUS FOLLOW-UP FORM)
Description

Documented clinical assessment for this cancer

Data type

text

Alias
NCI Thesaurus ValueDomain
C38148
UMLS CUI-1
C1522577
NCI Thesaurus Property
C16033
UMLS CUI-2
C0006826
NCI Thesaurus ObjectClass
C9305
NCI Thesaurus Property-2
C25365
Date
Description

Assessment Date

Data type

date

Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C2985720
NCI Thesaurus ObjectClass
C25367
NCI Thesaurus ValueDomain-2
C25367
NCI Thesaurus Property
C38000
Performance Status (ZUBROD 0-5, 9-UNKNOWN)
Description

ECOG Performance Status

Data type

text

Alias
NCI Thesaurus ValueDomain
C25664
UMLS CUI-1
C1520224
NCI Thesaurus Property
C25367
NCI Thesaurus ValueDomain-2
C25491
NCI Thesaurus ObjectClass
C20641
Unnamed Module 6
Description

Unnamed Module 6

Has the patient had a prostate biopsy (SINCE SUBMISSION OF THE LAST FOLLOW-UP FORM)
Description

Prostate Biopsy

Data type

text

Alias
NCI Thesaurus ObjectClass
C15189
UMLS CUI-1
C0194804
NCI Thesaurus ObjectClass-2
C12410
NCI Thesaurus Property
C38000
NCI Thesaurus ValueDomain
C25688
Biopsy Date
Description

Biopsy Date

Data type

date

Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0005558
NCI Thesaurus ValueDomain-2
C25367
NCI Thesaurus ObjectClass
C15189
UMLS CUI-2
C0011008
NCI Thesaurus Property
C25275
Is the tumor palpable
Description

Palpable Tumor

Data type

text

Alias
NCI Thesaurus ValueDomain
C25180
UMLS CUI-1
C0746412
NCI Thesaurus ObjectClass
C3262
NCI Thesaurus Property
C25626
NCI Thesaurus ObjectClass-2
C25606
Unnamed Module 5
Description

Unnamed Module 5

Has the patient been diagnosed with biochemical recurrence since submission of the last follow-up form
Description

PSA Failure

Data type

text

Alias
NCI Thesaurus ValueDomain
C38148
UMLS CUI-1
C2985506
NCI Thesaurus Property
C25626
NCI Thesaurus ObjectClass
C25331
NCI Thesaurus ObjectClass-2
C25434
Has the patient been diagnosed with a first local recurrence (SINCE SUBMISSION OF LAST FOLLOW-UP FORM See Protocol Section 11)
Description

Neoplasm recurrence, Local

Data type

text

Alias
NCI Thesaurus ObjectClass
C19987
UMLS CUI-1
C0027643
NCI Thesaurus Property
C67263
NCI Thesaurus Property-2
C25509
NCI Thesaurus Property-3
C15220
NCI Thesaurus ValueDomain
C38148
Date
Description

Date of Neoplasm local recurrence

Data type

date

Alias
NCI Thesaurus ObjectClass
C3352
UMLS CUI-1
C0027643
NCI Thesaurus ObjectClass-2
C25388
UMLS CUI-2
C0011008
NCI Thesaurus Property
C25509
NCI Thesaurus Property-2
C15220
NCI Thesaurus ValueDomain
C25164
Other Specify
Description

Evaluation method, specify

Data type

text

Alias
NCI Thesaurus ValueDomain
C25685
UMLS CUI-1
C2911685
NCI Thesaurus ObjectClass
C20989
UMLS CUI-2
C1521902
NCI Thesaurus Property
C16847
Other Specify
Description

Evaluation method, specify

Data type

text

Alias
NCI Thesaurus ValueDomain
C25685
UMLS CUI-1
C2911685
NCI Thesaurus ObjectClass
C20989
UMLS CUI-2
C1521902
NCI Thesaurus Property
C16847
Has the patient been diagnosed with first distant progression (SINCE SUBMISSION OF THE LAST FOLLOW-UP FORM)
Description

Neoplasm recurrence, Distal

Data type

text

Alias
NCI Thesaurus ObjectClass
C19987
UMLS CUI-1
C0027627
NCI Thesaurus Property
C25321
NCI Thesaurus Property-2
C25509
NCI Thesaurus Property-3
C15220
NCI Thesaurus ValueDomain
C25180
Date
Description

Date of Neoplasm distal recurrence

Data type

date

Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0027627
NCI Thesaurus ObjectClass
C25331
NCI Thesaurus ValueDomain-2
C25509
UMLS CUI-2
C0011008
NCI Thesaurus Property
C25275
Sites of Progression (First distant)
Description

Progression Sites

Data type

text

Alias
NCI Thesaurus ValueDomain
C25704
UMLS CUI-1
C0280457
NCI Thesaurus Property
C25341
NCI Thesaurus ObjectClass
C25331
Method of Evaluation (DISTANT PROGRESSION)
Description

Evaluation method

Data type

text

Alias
NCI Thesaurus ValueDomain
C25284
UMLS CUI-1
C2911685
NCI Thesaurus ObjectClass
C20989
NCI Thesaurus Property
C16847
Method of Evaluation (DISTANT PROGRESSION)
Description

Evaluation method

Data type

text

Alias
NCI Thesaurus ValueDomain
C25284
UMLS CUI-1
C2911685
NCI Thesaurus ObjectClass
C20989
NCI Thesaurus Property
C16847
Unnamed Module 4a
Description

Unnamed Module 4a

PSA Date (s)
Description

PSA date

Data type

date

Alias
NCI Thesaurus ObjectClass
C25294
UMLS CUI-1
C0138741
NCI Thesaurus Property
C17525
UMLS CUI-2
C0011008
NCI Thesaurus Property-2
C20200
NCI Thesaurus Property-3
C17220
NCI Thesaurus ValueDomain
C25164
NCI Thesaurus ValueDomain-2
C25367
PSA Value (s)
Description

PSA

Data type

float

Measurement units
  • ng/ml
Alias
NCI Thesaurus ObjectClass
C25294
UMLS CUI-1
C0138741
NCI Thesaurus Property
C17525
NCI Thesaurus Property-2
C20200
NCI Thesaurus Property-3
C17220
NCI Thesaurus ValueDomain
C25712
ng/ml
Units
Description

AssessmentLabUOM

Data type

text

Alias
NCI Thesaurus ObjectClass
C20989
UMLS 2011AA ObjectClass
C0031809
NCI Thesaurus Property
C37984
UMLS 2011AA Property
C0022877
NCI Thesaurus ValueDomain
C25709
UMLS 2011AA ValueDomain
C1519795
Method of Assay
Description

PSAManufacturerAssayType

Data type

text

Alias
NCI Thesaurus ValueDomain
C25284
UMLS 2011AA ValueDomain
C0332307
NCI Thesaurus ObjectClass
C17525
UMLS 2011AA ObjectClass
C0138741
NCI Thesaurus Property
C16341
UMLS 2011AA Property
C0005507
NCI Thesaurus Property-2
C25392
UMLS 2011AA Property-2
C0947322
Treatment Schedule (lhrh Agonist)
Description

Treatment Schedule (lhrh Agonist)

Is patient on protocol hormone (ORAL ANTIANDROGEN)
Description

ProtocolHormoneTherapyPatientCurrentReceivedInd-3

Data type

boolean

Alias
NCI Thesaurus ObjectClass
C16960
UMLS 2011AA ObjectClass
C0030705
NCI Thesaurus ObjectClass-2
C25320
UMLS 2011AA ObjectClass-2
C1507394
NCI Thesaurus ObjectClass-3
C15445
UMLS 2011AA ObjectClass-3
C0279025
NCI Thesaurus Property
C25471
UMLS 2011AA Property
C0521116
NCI Thesaurus Property-2
C25639
UMLS 2011AA Property-2
C1514756
NCI Thesaurus ValueDomain
C38148
UMLS 2011AA ValueDomain
C1512699
LHRH agonist (OR ANTAGONIST)
Description

HormoneTherapyLuteinizingHormone-releasingHormoneAgonistAdministrationName

Data type

text

Alias
NCI Thesaurus ObjectClass
C15445
UMLS 2011AA ObjectClass
C0279025
NCI Thesaurus Property
C25409
UMLS 2011AA Property
C1533734
NCI Thesaurus ValueDomain
C42614
UMLS 2011AA ValueDomain
C0027365
NCI Thesaurus Property-2
C1910
UMLS 2011AA Property-2
C1518041
Other, specify
Description

HormoneTherapyLuteinizingHormone-releasingHormoneAgonistAdministrationSpecify

Data type

text

Alias
NCI Thesaurus ValueDomain
C25685
UMLS 2011AA ValueDomain
C1521902
NCI Thesaurus ObjectClass
C15445
UMLS 2011AA ObjectClass
C0279025
NCI Thesaurus Property
C25409
UMLS 2011AA Property
C1533734
NCI Thesaurus Property-2
C1910
UMLS 2011AA Property-2
C1518041
LHRH agonist start date (OR ANTAGONIST IF STARTED IN THIS FOLLOW-UP PERIOD)
Description

HormoneTherapyLuteinizingHormone-releasingHormoneAgonistAdministrationBeginDate

Data type

date

Alias
NCI Thesaurus ObjectClass
C15445
UMLS 2011AA ObjectClass
C0279025
NCI Thesaurus Property
C25409
UMLS 2011AA Property
C1533734
NCI Thesaurus Property-2
C1910
UMLS 2011AA Property-2
C1518041
NCI Thesaurus ValueDomain
C25164
UMLS 2011AA ValueDomain
C0011008
NCI Thesaurus ValueDomain-2
C25431
UMLS 2011AA ValueDomain-2
C0439659
LHRH agonist end date (OR ANTAGONIST IF TERMINATED IN THIS FOLLOW-UP PERIOD)
Description

HormoneTherapyLuteinizingHormone-releasingHormoneAgonistAdministrationEndDate

Data type

date

Alias
NCI Thesaurus ValueDomain
C25164
UMLS 2011AA ValueDomain
C0011008
NCI Thesaurus ObjectClass
C15445
UMLS 2011AA ObjectClass
C0279025
NCI Thesaurus Property
C25409
UMLS 2011AA Property
C1533734
NCI Thesaurus Property-2
C1910
UMLS 2011AA Property-2
C1518041
Reason Treatment Ended (ORAL ANTIANDROGEN)
Description

Off Treatment Reason

Data type

text

Alias
NCI Thesaurus ValueDomain
C25638
UMLS CUI-1
C1518544
NCI Thesaurus ObjectClass
C25601
UMLS CUI-2
C0566251
NCI Thesaurus Property
C25365
Alternative Therapy, Specify
Description

Off-treatmentAlternativeReasonSpecify

Data type

text

Alias
NCI Thesaurus ValueDomain
C25685
UMLS 2011AA ValueDomain
C1521902
NCI Thesaurus ObjectClass
C25601
UMLS 2011AA ObjectClass
C1518544
NCI Thesaurus Property
C25415
UMLS 2011AA Property
C1523987
NCI Thesaurus Property-2
C25365
UMLS 2011AA Property-2
C0678257
Patient off-treatment for other complicating disease, specify
Description

Off-TreatmentConditionSpecify

Data type

text

Alias
NCI Thesaurus ValueDomain
C25685
UMLS 2011AA ValueDomain
C1521902
NCI Thesaurus ObjectClass
C25601
UMLS 2011AA ObjectClass
C1518544
NCI Thesaurus Property
C25457
UMLS 2011AA Property
C0348080
Other specify
Description

Off Treatment Reason, specify

Data type

text

Alias
NCI Thesaurus ValueDomain
C25685
UMLS CUI-1
C1518544
NCI Thesaurus ObjectClass
C25601
UMLS CUI-2
C0566251
NCI Thesaurus Property
C25365
UMLS CUI-3
C1521902
Total Dose (TO DATE)
Description

Cumulative Dose Agent

Data type

float

Alias
NCI Thesaurus ObjectClass
C1708
UMLS CUI-1
C2986497
NCI Thesaurus ObjectClass-2
C25470
UMLS CUI-2
C1521826
NCI Thesaurus Property
C25304
NCI Thesaurus Property-2
C25256
NCI Thesaurus ValueDomain
C25304
NCI Thesaurus ValueDomain-2
C25488
Treatment Schedule (oral Antiandrogen)
Description

Treatment Schedule (oral Antiandrogen)

Is patient on protocol hormone (ORAL ANTIANDROGEN)
Description

ProtocolHormoneTherapyPatientCurrentReceivedInd-3

Data type

boolean

Alias
NCI Thesaurus ObjectClass
C16960
UMLS 2011AA ObjectClass
C0030705
NCI Thesaurus ObjectClass-2
C25320
UMLS 2011AA ObjectClass-2
C1507394
NCI Thesaurus ObjectClass-3
C15445
UMLS 2011AA ObjectClass-3
C0279025
NCI Thesaurus Property
C25471
UMLS 2011AA Property
C0521116
NCI Thesaurus Property-2
C25639
UMLS 2011AA Property-2
C1514756
NCI Thesaurus ValueDomain
C38148
UMLS 2011AA ValueDomain
C1512699
Oral antiandrogen taken
Description

OralAntiandrogenTherapyAgentAdministeredName

Data type

text

Alias
NCI Thesaurus ObjectClass
C1708
UMLS 2011AA ObjectClass
C0450442
NCI Thesaurus ObjectClass-2
C25311
UMLS 2011AA ObjectClass-2
C0442027
NCI Thesaurus ObjectClass-3
C15481
UMLS 2011AA ObjectClass-3
C0279492
NCI Thesaurus Property
C25382
UMLS 2011AA Property
C1521801
NCI Thesaurus ValueDomain
C25191
UMLS 2011AA ValueDomain
C1547383
Other, specify
Description

OralAntiandrogenTherapyAgentAdministeredSpecify

Data type

text

Alias
NCI Thesaurus ObjectClass
C1708
UMLS 2011AA ObjectClass
C0450442
NCI Thesaurus ObjectClass-2
C25311
UMLS 2011AA ObjectClass-2
C0442027
NCI Thesaurus ObjectClass-3
C15481
UMLS 2011AA ObjectClass-3
C0279492
NCI Thesaurus Property
C25382
UMLS 2011AA Property
C1521801
NCI Thesaurus ValueDomain
C25685
UMLS 2011AA ValueDomain
C1521902
Oral Antiandrogen Start Date (IF STARTED IN THIS FOLLOW-UP PERIOD)
Description

OralAntiandrogenTherapyAgentAdministeredBeginDate

Data type

date

Alias
NCI Thesaurus ObjectClass
C1708
UMLS 2011AA ObjectClass
C0450442
NCI Thesaurus ObjectClass-2
C25311
UMLS 2011AA ObjectClass-2
C0442027
NCI Thesaurus ObjectClass-3
C15481
UMLS 2011AA ObjectClass-3
C0279492
NCI Thesaurus Property
C25382
UMLS 2011AA Property
C1521801
NCI Thesaurus ValueDomain
C25164
UMLS 2011AA ValueDomain
C0011008
NCI Thesaurus ValueDomain-2
C25431
UMLS 2011AA ValueDomain-2
C0439659
Oral Antiandrogen End Date (IF TERMINATED IN THIS FOLLOW-UP PERIOD)
Description

OralAntiandrogenTherapyAgentAdministeredEndDate

Data type

date

Alias
NCI Thesaurus ObjectClass
C1708
UMLS 2011AA ObjectClass
C0450442
NCI Thesaurus ObjectClass-2
C25311
UMLS 2011AA ObjectClass-2
C0442027
NCI Thesaurus ObjectClass-3
C15481
UMLS 2011AA ObjectClass-3
C0279492
NCI Thesaurus Property
C25382
UMLS 2011AA Property
C1521801
NCI Thesaurus ValueDomain
C25164
UMLS 2011AA ValueDomain
C0011008
Reason Treatment Ended (ORAL ANTIANDROGEN)
Description

Off Treatment Reason

Data type

text

Alias
NCI Thesaurus ValueDomain
C25638
UMLS CUI-1
C1518544
NCI Thesaurus ObjectClass
C25601
UMLS CUI-2
C0566251
NCI Thesaurus Property
C25365
Alternative Therapy, Specify
Description

Off-treatmentAlternativeReasonSpecify

Data type

text

Alias
NCI Thesaurus ValueDomain
C25685
UMLS 2011AA ValueDomain
C1521902
NCI Thesaurus ObjectClass
C25601
UMLS 2011AA ObjectClass
C1518544
NCI Thesaurus Property
C25415
UMLS 2011AA Property
C1523987
NCI Thesaurus Property-2
C25365
UMLS 2011AA Property-2
C0678257
Patient off-treatment for other complicating disease, specify
Description

Off-TreatmentConditionSpecify

Data type

text

Alias
NCI Thesaurus ValueDomain
C25685
UMLS 2011AA ValueDomain
C1521902
NCI Thesaurus ObjectClass
C25601
UMLS 2011AA ObjectClass
C1518544
NCI Thesaurus Property
C25457
UMLS 2011AA Property
C0348080
Other specify
Description

Off Treatment Reason, specify

Data type

text

Alias
NCI Thesaurus ValueDomain
C25685
UMLS CUI-1
C1518544
NCI Thesaurus ObjectClass
C25601
UMLS CUI-2
C0566251
NCI Thesaurus Property
C25365
UMLS CUI-3
C1521902
Total Dose (TO DATE)
Description

Cumulative Dose Agent

Data type

float

Alias
NCI Thesaurus ObjectClass
C1708
UMLS CUI-1
C2986497
NCI Thesaurus ObjectClass-2
C25470
UMLS CUI-2
C1521826
NCI Thesaurus Property
C25304
NCI Thesaurus Property-2
C25256
NCI Thesaurus ValueDomain
C25304
NCI Thesaurus ValueDomain-2
C25488
Non-protocol Therapy
Description

Non-protocol Therapy

Is the patient receiving any non-protocol cancer therapy not previously reported (PROSTATE If yes, enter therapy type and date for each therapy delivered during the follow-up period.)
Description

Non-protocolTherapyAdministeredInd-3

Data type

text

Alias
NCI Thesaurus ValueDomain
C38148
UMLS 2011AA ValueDomain
C1512699
NCI Thesaurus ObjectClass
C15368
NCI Thesaurus ObjectClass-2
C25590
UMLS 2011AA ObjectClass
C1518384
NCI Thesaurus Property
C25382
UMLS 2011AA Property
C1521801
Non-Protocol Therapy Type
Description

Non-ProtocolTherapyAdministeredType

Data type

text

Alias
NCI Thesaurus ValueDomain
C25284
UMLS 2011AA ValueDomain
C0332307
NCI Thesaurus ObjectClass
C15368
NCI Thesaurus ObjectClass-2
C25590
UMLS 2011AA ObjectClass
C1518384
NCI Thesaurus Property
C25382
UMLS 2011AA Property
C1521801
Date of First Non-Protocol Therapy
Description

Non-ProtocolTherapyFirstAdministeredDate

Data type

date

Alias
NCI Thesaurus ObjectClass
C15368
NCI Thesaurus ObjectClass-2
C25590
UMLS 2011AA ObjectClass
C1518384
NCI Thesaurus Property
C25509
UMLS 2011AA Property
C1279901
NCI Thesaurus Property-2
C25382
UMLS 2011AA Property-2
C1521801
NCI Thesaurus ValueDomain
C25164
UMLS 2011AA ValueDomain
C0011008
NCI Thesaurus ValueDomain-2
C25367
Specify
Description

Non-ProtocolTreatmentFirstAdministeredSpecify

Data type

text

Alias
NCI Thesaurus ObjectClass
C15368
NCI Thesaurus ObjectClass-2
C25590
UMLS 2011AA ObjectClass
C1518384
NCI Thesaurus Property
C25509
UMLS 2011AA Property
C1279901
NCI Thesaurus Property-2
C25382
UMLS 2011AA Property-2
C1521801
NCI Thesaurus ValueDomain
C25685
UMLS 2011AA ValueDomain
C1521902
Unnamed Module 7
Description

Unnamed Module 7

Has a new primary cancer or MDS been diagnosed that has not been previously reported? (MYELODYSPLASTIC SYNDROME)
Description

NewCancerDiagnosisInd-3

Data type

text

Alias
NCI Thesaurus ValueDomain
C38148
UMLS 2011AA ValueDomain
C1512699
NCI Thesaurus ObjectClass
C25586
UMLS 2011AA ObjectClass
C0205314
NCI Thesaurus ObjectClass-2
C9305
UMLS 2011AA ObjectClass-2
C0006826
NCI Thesaurus Property
C15220
UMLS 2011AA Property
C0011900
Second Primary Tumor Site
Description

Second Primary Tumor Site

Data type

text

Alias
NCI Thesaurus ValueDomain
C13717
UMLS CUI-1
C0751623
NCI Thesaurus ObjectClass
C3262
UMLS CUI-2
C1515974
NCI Thesaurus Property
C25341
NCI Thesaurus ObjectClass-2
C25666
Second Primary Cancer Date
Description

Second Primary Tumor Date

Data type

date

Alias
NCI Thesaurus ObjectClass
C3262
UMLS CUI-1
C0751623
NCI Thesaurus ObjectClass-2
C25251
UMLS CUI-2
C0011008
NCI Thesaurus ObjectClass-3
C25666
NCI Thesaurus Property
C15220
NCI Thesaurus ValueDomain
C25164
Other specify
Description

Primary Disease Site

Data type

text

Alias
NCI Thesaurus ValueDomain
C25685
UMLS CUI-1
C0449695
NCI Thesaurus Property
C25341
NCI Thesaurus ObjectClass
C25251
NCI Thesaurus ObjectClass-2
C2991
Baseline Lab Values (hematologic)
Description

Baseline Lab Values (hematologic)

Date (s)
Description

Laboratory Procedure Date

Data type

date

Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0022885
NCI Thesaurus Property
C25214
UMLS CUI-2
C0011008
NCI Thesaurus Property-2
C38000
NCI Thesaurus ObjectClass
C25294
Date (s)
Description

Laboratory Procedure Date

Data type

date

Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0022885
NCI Thesaurus Property
C25214
UMLS CUI-2
C0011008
NCI Thesaurus Property-2
C38000
NCI Thesaurus ObjectClass
C25294
Date (s)
Description

Laboratory Procedure Date

Data type

date

Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0022885
NCI Thesaurus Property
C25214
UMLS CUI-2
C0011008
NCI Thesaurus Property-2
C38000
NCI Thesaurus ObjectClass
C25294
Date (s)
Description

Laboratory Procedure Date

Data type

date

Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C0022885
NCI Thesaurus Property
C25214
UMLS CUI-2
C0011008
NCI Thesaurus Property-2
C38000
NCI Thesaurus ObjectClass
C25294
WBC (mm^3)
Description

Leukocytes (WBC)

Data type

float

Alias
NCI Thesaurus ObjectClass
C25294
UMLS CUI-1
C0023508
NCI Thesaurus Property
C12529
NCI Thesaurus Property-2
C20200
NCI Thesaurus ValueDomain
C38046
NCI Thesaurus ValueDomain-2
C25712
Hemoglobin (g/dL)
Description

Hemoglobin

Data type

float

Measurement units
  • g/dL
Alias
NCI Thesaurus Property
C16676
UMLS CUI-1
C0019046
NCI Thesaurus Property-2
C20200
NCI Thesaurus ObjectClass
C25294
NCI Thesaurus ValueDomain
C25712
g/dL
Peripheral Platelet Count (mm^3)
Description

Platelets

Data type

float

Measurement units
  • 1000/uL
Alias
NCI Thesaurus Property
C20200
UMLS CUI-1
C0005821
NCI Thesaurus Property-2
C12520
NCI Thesaurus ObjectClass
C25294
NCI Thesaurus ValueDomain
C25712
1000/uL
ANC (mm^3)
Description

Neutrophil count

Data type

float

Alias
NCI Thesaurus ObjectClass
C25294
UMLS CUI-1
C0200633
NCI Thesaurus Property
C12533
NCI Thesaurus Property-2
C20200
NCI Thesaurus ValueDomain
C25304
NCI Thesaurus ValueDomain-2
C25712
Protocol Specific Adverse Event Evaluation
Description

Protocol Specific Adverse Event Evaluation

Any Treatment Related Adverse Events
Description

Adverse Event

Data type

text

Alias
NCI Thesaurus ObjectClass
C25648
UMLS CUI-1
C0877248
NCI Thesaurus ObjectClass-2
C41331
NCI Thesaurus ObjectClass-3
C15368
NCI Metathesaurus Property
C0684224
NCI Thesaurus ValueDomain
C38148
MedDRA Disease Code
Description

Primary Site MedDRA Code

Data type

float

Alias
NCI Thesaurus ObjectClass
C41331
UMLS CUI-1
C0449695
NCI Thesaurus ObjectClass-2
C71886
UMLS CUI-2
C1552878
NCI Thesaurus Property
C25162
NCI Thesaurus Property-2
C43820
NCI Thesaurus ValueDomain
C25162
NCI Thesaurus ValueDomain-2
C41331
NCI Thesaurus ValueDomain-3
C45255
NCI Thesaurus ValueDomain-4
C43820
NCI Thesaurus ValueDomain-5
C25714
CTC Adverse Event Term (OTHER CTC ADVERSE EVENT NOT LISTED)
Description

CommonTerminologyCriteriaforAdverseEventsVersion4.0LowLevelTermName

Data type

text

Alias
NCI Thesaurus ObjectClass
C41331
UMLS 2011AA ObjectClass
C0877248
NCI Thesaurus Property
C49704
UMLS 2011AA Property
C1516728
NCI Thesaurus Property-2
C45559
UMLS 2011AA Property-2
C1705313
NCI Thesaurus ValueDomain
C45255
UMLS 2011AA ValueDomain
C1708523
NCI Thesaurus ValueDomain-2
C49704
UMLS 2011AA ValueDomain-2
C1516728
NCI Thesaurus ValueDomain-3
C42614
UMLS 2011AA ValueDomain-3
C0027365
NCI Thesaurus ValueDomain-4
C45559
UMLS 2011AA ValueDomain-4
C1705313
NCI Thesaurus ValueDomain-5
C25714
UMLS 2011AA ValueDomain-5
C0333052
CTC AE Grade
Description

AdverseEventSeverityGrade

Data type

text

Alias
NCI Thesaurus ObjectClass
C41331
UMLS 2011AA ObjectClass
C0877248
NCI Thesaurus Property
C48309
UMLS 2011AA Property
C0441800
NCI Thesaurus Property-2
C49705
UMLS 2011AA Property-2
C1710065
NCI Thesaurus Property-3
C25676
UMLS 2011AA Property-3
C0439793
NCI Thesaurus ValueDomain
C41331
UMLS 2011AA ValueDomain
C0877248
NCI Thesaurus ValueDomain-2
C48309
UMLS 2011AA ValueDomain-2
C0441800
NCI Thesaurus ValueDomain-3
C25676
UMLS 2011AA ValueDomain-3
C0439793
CTCAE Begin Date
Description

Adverse Event Start Date

Data type

date

Alias
NCI Thesaurus ValueDomain
C25164
UMLS CUI-1
C2697888
NCI Thesaurus Property
C25375
NCI Thesaurus ValueDomain-2
C25431
NCI Thesaurus ObjectClass
C49704
CTC AE Attribution Code
Description

CTC Adverse Event Attribution Category

Data type

text

Alias
NCI Thesaurus ValueDomain
C25664
UMLS CUI-1
C1706735
NCI Thesaurus ObjectClass
C49704
NCI Thesaurus Property
C25358
SAE report submitted
Description

SAE report

Data type

text

Alias
NCI Thesaurus ValueDomain
C38148
UMLS CUI-1
C1519255
NCI Thesaurus ObjectClass
C41331
UMLS CUI-2
C0684224
NCI Thesaurus Property
C25375
NCI Thesaurus ObjectClass-2
C54035
Footer
Description

Footer

Comments
Description

Research Comments

Data type

text

Alias
NCI Thesaurus ValueDomain
C25704
UMLS CUI-1
C0947611
NCI Thesaurus ObjectClass
C15319
NCI Thesaurus Property
C25393
Signature of Person Completing This Form
Description

Responsible Person Signature

Data type

text

Alias
NCI Thesaurus ValueDomain
C25704
UMLS CUI-1
C1550483
NCI Thesaurus ObjectClass
C25190
NCI Thesaurus ObjectClass-2
C25657
NCI Thesaurus Property
C25678
Date Form Originally Completed
Description

Form Completion Date

Data type

date

Alias
NCI Thesaurus ObjectClass
C19464
UMLS CUI-1
C1549507
NCI Thesaurus Property
C25250
NCI Thesaurus Property-2
C25604
NCI Thesaurus ValueDomain
C25164
NCI Thesaurus ValueDomain-2
C25367

Similar models

INSTRUCTIONS: Submit this form at the appropriate follow-up interval. All dates to be reported mm-dd-yyyy unless otherwise indicated

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Unnamed2
Protocol ID RTOG
Item
RTOG Study No.
text
C25337 (NCI Thesaurus ValueDomain)
C3274381 (UMLS CUI-1)
C25320 (NCI Thesaurus ObjectClass)
C1514695 (UMLS CUI-2)
C19778 (NCI Thesaurus Property)
C25364 (NCI Thesaurus Property-2)
RadiationTherapyOncologyGroupPatientCaseIdentifierNumber
Item
Case #
text
C16960 (NCI Thesaurus ObjectClass)
C0030705 (UMLS 2011AA ObjectClass)
C19778 (NCI Thesaurus ObjectClass-2)
C1514695 (UMLS 2011AA ObjectClass-2)
C25364 (NCI Thesaurus Property)
C0600091 (UMLS 2011AA Property)
C49152 (NCI Thesaurus Property-2)
C1706256 (UMLS 2011AA Property-2)
C25337 (NCI Thesaurus ValueDomain)
C0237753 (UMLS 2011AA ValueDomain)
Institution Name
Item
Institution Name
text
C25191 (NCI Thesaurus ValueDomain)
C1301943 (UMLS CUI-1)
C21541 (NCI Thesaurus ObjectClass)
C21541 (NCI Thesaurus ValueDomain-2)
C25364 (NCI Thesaurus Property)
Institution Number
Item
Institution No.
text
C25337 (NCI Thesaurus ValueDomain)
C1301943 (UMLS CUI-1)
C21541 (NCI Thesaurus ObjectClass)
C0805701 (UMLS CUI-2)
C25364 (NCI Thesaurus Property)
Patient Initials
Item
Patient Initials
text
C25191 (NCI Thesaurus ValueDomain)
C2986440 (UMLS CUI-1)
C16960 (NCI Thesaurus ObjectClass)
C25536 (NCI Thesaurus Property)
Trial subject ID RTOG
Item
RTOG Patient ID
text
C25337 (NCI Thesaurus ValueDomain)
C2348585 (UMLS CUI-1)
C16960 (NCI Thesaurus ObjectClass)
C1514695 (UMLS CUI-2)
C19778 (NCI Thesaurus Property)
C25364 (NCI Thesaurus Property-2)
Item Group
Header
Data amended
Item
Amended Data
boolean
C38148 (NCI Thesaurus ValueDomain)
C0680532 (UMLS CUI-1)
C25474 (NCI Thesaurus ObjectClass)
C25416 (NCI Thesaurus Property)
Item Group
Unnamed 3
Item
Patient's Vital Status
text
C16960 (NCI Thesaurus ObjectClass)
C3846084 (UMLS CUI-1)
C18003 (NCI Thesaurus ValueDomain)
C25688 (NCI Thesaurus ValueDomain-2)
C25717 (NCI Thesaurus Property)
Code List
Patient's Vital Status
CL Item
Alive (Alive)
CL Item
Dead (Dead)
Date last contact
Item
Date of Last Contact or Death
date
C16960 (NCI Thesaurus ObjectClass)
C0805839 (UMLS CUI-1)
C25461 (NCI Thesaurus Property)
C25551 (NCI Thesaurus Property-2)
C25164 (NCI Thesaurus ValueDomain)
C25367 (NCI Thesaurus ValueDomain-2)
Item
Primary Cause of Death
text
C25638 (NCI Thesaurus ValueDomain)
C0007465 (UMLS CUI-1)
C16960 (NCI Thesaurus ObjectClass)
C28554 (NCI Thesaurus Property)
C25251 (NCI Thesaurus ValueDomain-2)
Code List
Primary Cause of Death
CL Item
Not Applicable (Not applicable)
C48660 (NCI Thesaurus)
C1272460 (UMLS 2011AA)
CL Item
Due To This Disease (Due to this disease)
CL Item
Due To Protocol Treatment (Due to protocol treatment)
CL Item
Due To Other Cause (Due to other cause)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Primary Cause of Death, specify
Item
Due to other cause, specify
text
C16960 (NCI Thesaurus ObjectClass)
C0007465 (UMLS CUI-1)
C25251 (NCI Thesaurus ObjectClass-2)
C0007465 (NCI Metathesaurus ObjectClass)
C17649 (NCI Thesaurus Property)
C25365 (NCI Thesaurus Property-2)
C25685 (NCI Thesaurus ValueDomain)
Item
Has the patient had a documented clinical assessment for this cancer (SINCE SUBMISSION OF THE PREVIOUS FOLLOW-UP FORM)
text
C38148 (NCI Thesaurus ValueDomain)
C1522577 (UMLS CUI-1)
C16033 (NCI Thesaurus Property)
C0006826 (UMLS CUI-2)
C9305 (NCI Thesaurus ObjectClass)
C25365 (NCI Thesaurus Property-2)
Code List
Has the patient had a documented clinical assessment for this cancer (SINCE SUBMISSION OF THE PREVIOUS FOLLOW-UP FORM)
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Assessment Date
Item
Date
date
C25164 (NCI Thesaurus ValueDomain)
C2985720 (UMLS CUI-1)
C25367 (NCI Thesaurus ObjectClass)
C25367 (NCI Thesaurus ValueDomain-2)
C38000 (NCI Thesaurus Property)
Item
Performance Status (ZUBROD 0-5, 9-UNKNOWN)
text
C25664 (NCI Thesaurus ValueDomain)
C1520224 (UMLS CUI-1)
C25367 (NCI Thesaurus Property)
C25491 (NCI Thesaurus ValueDomain-2)
C20641 (NCI Thesaurus ObjectClass)
Code List
Performance Status (ZUBROD 0-5, 9-UNKNOWN)
CL Item
Fully Active, Able To Carry On All Pre-disease Performance Without Restriction. (0)
CL Item
Restricted In Physically Strenuous Activity But Ambulatory And Able To Carry Out Work Of A Light Or Sedentary Nature, E.g., Light Housework, Office Work. (1)
CL Item
Ambulatory And Capable Of All Selfcare But Unable To Carry Out Any Work Activities. Up And About More Than 50% Of Waking Hours. (2)
CL Item
Capable Of Only Limited Selfcare, Confined To Bed Or Chair More Than 50% Of Waking Hours. (3)
CL Item
Completely Disabled. Cannot Carry On Any Selfcare. Totally Confined To Bed Or Chair. (4)
CL Item
Dead (5)
Item Group
Unnamed Module 6
Item
Has the patient had a prostate biopsy (SINCE SUBMISSION OF THE LAST FOLLOW-UP FORM)
text
C15189 (NCI Thesaurus ObjectClass)
C0194804 (UMLS CUI-1)
C12410 (NCI Thesaurus ObjectClass-2)
C38000 (NCI Thesaurus Property)
C25688 (NCI Thesaurus ValueDomain)
Code List
Has the patient had a prostate biopsy (SINCE SUBMISSION OF THE LAST FOLLOW-UP FORM)
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes, Negative (Yes, negative)
CL Item
Yes, Positive (Yes, positive)
CL Item
Yes, Results Unknown (Yes, results unknown)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Biopsy Date
Item
Biopsy Date
date
C25164 (NCI Thesaurus ValueDomain)
C0005558 (UMLS CUI-1)
C25367 (NCI Thesaurus ValueDomain-2)
C15189 (NCI Thesaurus ObjectClass)
C0011008 (UMLS CUI-2)
C25275 (NCI Thesaurus Property)
Item
Is the tumor palpable
text
C25180 (NCI Thesaurus ValueDomain)
C0746412 (UMLS CUI-1)
C3262 (NCI Thesaurus ObjectClass)
C25626 (NCI Thesaurus Property)
C25606 (NCI Thesaurus ObjectClass-2)
Code List
Is the tumor palpable
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Equivocal (Equivocal)
C86071 (NCI Thesaurus)
C0332241 (UMLS 2011AA)
CL Item
Not Evaluated (Not evaluated)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Item Group
Unnamed Module 5
Item
Has the patient been diagnosed with biochemical recurrence since submission of the last follow-up form
text
C38148 (NCI Thesaurus ValueDomain)
C2985506 (UMLS CUI-1)
C25626 (NCI Thesaurus Property)
C25331 (NCI Thesaurus ObjectClass)
C25434 (NCI Thesaurus ObjectClass-2)
Code List
Has the patient been diagnosed with biochemical recurrence since submission of the last follow-up form
CL Item
No (NO)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
C49487 (NCI Thesaurus-3)
C1298908 (UMLS 2011AA-4)
CL Item
Yes (YES)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
C49488 (NCI Thesaurus-3)
C1705108 (UMLS 2011AA-4)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Item
Has the patient been diagnosed with a first local recurrence (SINCE SUBMISSION OF LAST FOLLOW-UP FORM See Protocol Section 11)
text
C19987 (NCI Thesaurus ObjectClass)
C0027643 (UMLS CUI-1)
C67263 (NCI Thesaurus Property)
C25509 (NCI Thesaurus Property-2)
C15220 (NCI Thesaurus Property-3)
C38148 (NCI Thesaurus ValueDomain)
Code List
Has the patient been diagnosed with a first local recurrence (SINCE SUBMISSION OF LAST FOLLOW-UP FORM See Protocol Section 11)
CL Item
No (NO)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
C49487 (NCI Thesaurus-3)
C1298908 (UMLS 2011AA-4)
CL Item
Yes (YES)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
C49488 (NCI Thesaurus-3)
C1705108 (UMLS 2011AA-4)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Date of Neoplasm local recurrence
Item
Date
date
C3352 (NCI Thesaurus ObjectClass)
C0027643 (UMLS CUI-1)
C25388 (NCI Thesaurus ObjectClass-2)
C0011008 (UMLS CUI-2)
C25509 (NCI Thesaurus Property)
C15220 (NCI Thesaurus Property-2)
C25164 (NCI Thesaurus ValueDomain)
Evaluation method, specify
Item
Other Specify
text
C25685 (NCI Thesaurus ValueDomain)
C2911685 (UMLS CUI-1)
C20989 (NCI Thesaurus ObjectClass)
C1521902 (UMLS CUI-2)
C16847 (NCI Thesaurus Property)
Evaluation method, specify
Item
Other Specify
text
C25685 (NCI Thesaurus ValueDomain)
C2911685 (UMLS CUI-1)
C20989 (NCI Thesaurus ObjectClass)
C1521902 (UMLS CUI-2)
C16847 (NCI Thesaurus Property)
Item
Has the patient been diagnosed with first distant progression (SINCE SUBMISSION OF THE LAST FOLLOW-UP FORM)
text
C19987 (NCI Thesaurus ObjectClass)
C0027627 (UMLS CUI-1)
C25321 (NCI Thesaurus Property)
C25509 (NCI Thesaurus Property-2)
C15220 (NCI Thesaurus Property-3)
C25180 (NCI Thesaurus ValueDomain)
Code List
Has the patient been diagnosed with first distant progression (SINCE SUBMISSION OF THE LAST FOLLOW-UP FORM)
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Date of Neoplasm distal recurrence
Item
Date
date
C25164 (NCI Thesaurus ValueDomain)
C0027627 (UMLS CUI-1)
C25331 (NCI Thesaurus ObjectClass)
C25509 (NCI Thesaurus ValueDomain-2)
C0011008 (UMLS CUI-2)
C25275 (NCI Thesaurus Property)
Progression Sites
Item
Sites of Progression (First distant)
text
C25704 (NCI Thesaurus ValueDomain)
C0280457 (UMLS CUI-1)
C25341 (NCI Thesaurus Property)
C25331 (NCI Thesaurus ObjectClass)
Item
Method of Evaluation (DISTANT PROGRESSION)
text
C25284 (NCI Thesaurus ValueDomain)
C2911685 (UMLS CUI-1)
C20989 (NCI Thesaurus ObjectClass)
C16847 (NCI Thesaurus Property)
Code List
Method of Evaluation (DISTANT PROGRESSION)
CL Item
Not Applicable (Not applicable)
C48660 (NCI Thesaurus)
C1272460 (UMLS 2011AA)
CL Item
Physical Exam (Physical exam)
CL Item
Pathologic (Pathologic)
C25610 (NCI Thesaurus)
C1521733 (UMLS 2011AA)
CL Item
Radiographic (Radiographic)
CL Item
Mri (MRI (NMR))
CL Item
Other (Other)
C17649 (NCI Thesaurus)
C0205394 (UMLS 2011AA)
Item
Method of Evaluation (DISTANT PROGRESSION)
text
C25284 (NCI Thesaurus ValueDomain)
C2911685 (UMLS CUI-1)
C20989 (NCI Thesaurus ObjectClass)
C16847 (NCI Thesaurus Property)
Code List
Method of Evaluation (DISTANT PROGRESSION)
CL Item
Not Applicable (Not applicable)
C48660 (NCI Thesaurus)
C1272460 (UMLS 2011AA)
CL Item
Physical Exam (Physical exam)
CL Item
Pathologic (Pathologic)
C25610 (NCI Thesaurus)
C1521733 (UMLS 2011AA)
CL Item
Radiographic (Radiographic)
CL Item
Mri (MRI (NMR))
CL Item
Other (Other)
C17649 (NCI Thesaurus)
C0205394 (UMLS 2011AA)
Item Group
Unnamed Module 4a
PSA date
Item
PSA Date (s)
date
C25294 (NCI Thesaurus ObjectClass)
C0138741 (UMLS CUI-1)
C17525 (NCI Thesaurus Property)
C0011008 (UMLS CUI-2)
C20200 (NCI Thesaurus Property-2)
C17220 (NCI Thesaurus Property-3)
C25164 (NCI Thesaurus ValueDomain)
C25367 (NCI Thesaurus ValueDomain-2)
PSA
Item
PSA Value (s)
float
C25294 (NCI Thesaurus ObjectClass)
C0138741 (UMLS CUI-1)
C17525 (NCI Thesaurus Property)
C20200 (NCI Thesaurus Property-2)
C17220 (NCI Thesaurus Property-3)
C25712 (NCI Thesaurus ValueDomain)
Item
Units
text
C20989 (NCI Thesaurus ObjectClass)
C0031809 (UMLS 2011AA ObjectClass)
C37984 (NCI Thesaurus Property)
C0022877 (UMLS 2011AA Property)
C25709 (NCI Thesaurus ValueDomain)
C1519795 (UMLS 2011AA ValueDomain)
Code List
Units
CL Item
N/milligram (n/mg)
CL Item
Nanograms Per Milliliter (ng/mL)
CL Item
Units Per Liter (U/L)
CL Item
Nanograms Per Deciliter (ng/dL)
CL Item
Micrograms Per Liter (mcg/L)
CL Item
Not Otherwise Specified (NOS)
CL006269 (NCI Metathesaurus)
Item
Method of Assay
text
C25284 (NCI Thesaurus ValueDomain)
C0332307 (UMLS 2011AA ValueDomain)
C17525 (NCI Thesaurus ObjectClass)
C0138741 (UMLS 2011AA ObjectClass)
C16341 (NCI Thesaurus Property)
C0005507 (UMLS 2011AA Property)
C25392 (NCI Thesaurus Property-2)
C0947322 (UMLS 2011AA Property-2)
Code List
Method of Assay
CL Item
Abbott Labs (Abbott)
CL Item
Bayer (Bayer)
CL Item
Dpc (DPC)
CL Item
Hybritech (Hybritech)
CL Item
Other (Other)
C17649 (NCI Thesaurus)
C0205394 (UMLS 2011AA)
CL Item
Unknown (Unknown)
Item Group
Treatment Schedule (lhrh Agonist)
ProtocolHormoneTherapyPatientCurrentReceivedInd-3
Item
Is patient on protocol hormone (ORAL ANTIANDROGEN)
boolean
C16960 (NCI Thesaurus ObjectClass)
C0030705 (UMLS 2011AA ObjectClass)
C25320 (NCI Thesaurus ObjectClass-2)
C1507394 (UMLS 2011AA ObjectClass-2)
C15445 (NCI Thesaurus ObjectClass-3)
C0279025 (UMLS 2011AA ObjectClass-3)
C25471 (NCI Thesaurus Property)
C0521116 (UMLS 2011AA Property)
C25639 (NCI Thesaurus Property-2)
C1514756 (UMLS 2011AA Property-2)
C38148 (NCI Thesaurus ValueDomain)
C1512699 (UMLS 2011AA ValueDomain)
Item
LHRH agonist (OR ANTAGONIST)
text
C15445 (NCI Thesaurus ObjectClass)
C0279025 (UMLS 2011AA ObjectClass)
C25409 (NCI Thesaurus Property)
C1533734 (UMLS 2011AA Property)
C42614 (NCI Thesaurus ValueDomain)
C0027365 (UMLS 2011AA ValueDomain)
C1910 (NCI Thesaurus Property-2)
C1518041 (UMLS 2011AA Property-2)
Code List
LHRH agonist (OR ANTAGONIST)
CL Item
Zoladex (Zoladex)
CL Item
Lupron (Lupron)
C0701459 (NCI Metathesaurus)
CL Item
Eligard (Eligard)
CL Item
Viadur (Viadur)
CL Item
Other (Other)
C17649 (NCI Thesaurus)
C0205394 (UMLS 2011AA)
HormoneTherapyLuteinizingHormone-releasingHormoneAgonistAdministrationSpecify
Item
Other, specify
text
C25685 (NCI Thesaurus ValueDomain)
C1521902 (UMLS 2011AA ValueDomain)
C15445 (NCI Thesaurus ObjectClass)
C0279025 (UMLS 2011AA ObjectClass)
C25409 (NCI Thesaurus Property)
C1533734 (UMLS 2011AA Property)
C1910 (NCI Thesaurus Property-2)
C1518041 (UMLS 2011AA Property-2)
HormoneTherapyLuteinizingHormone-releasingHormoneAgonistAdministrationBeginDate
Item
LHRH agonist start date (OR ANTAGONIST IF STARTED IN THIS FOLLOW-UP PERIOD)
date
C15445 (NCI Thesaurus ObjectClass)
C0279025 (UMLS 2011AA ObjectClass)
C25409 (NCI Thesaurus Property)
C1533734 (UMLS 2011AA Property)
C1910 (NCI Thesaurus Property-2)
C1518041 (UMLS 2011AA Property-2)
C25164 (NCI Thesaurus ValueDomain)
C0011008 (UMLS 2011AA ValueDomain)
C25431 (NCI Thesaurus ValueDomain-2)
C0439659 (UMLS 2011AA ValueDomain-2)
HormoneTherapyLuteinizingHormone-releasingHormoneAgonistAdministrationEndDate
Item
LHRH agonist end date (OR ANTAGONIST IF TERMINATED IN THIS FOLLOW-UP PERIOD)
date
C25164 (NCI Thesaurus ValueDomain)
C0011008 (UMLS 2011AA ValueDomain)
C15445 (NCI Thesaurus ObjectClass)
C0279025 (UMLS 2011AA ObjectClass)
C25409 (NCI Thesaurus Property)
C1533734 (UMLS 2011AA Property)
C1910 (NCI Thesaurus Property-2)
C1518041 (UMLS 2011AA Property-2)
Item
Reason Treatment Ended (ORAL ANTIANDROGEN)
text
C25638 (NCI Thesaurus ValueDomain)
C1518544 (UMLS CUI-1)
C25601 (NCI Thesaurus ObjectClass)
C0566251 (UMLS CUI-2)
C25365 (NCI Thesaurus Property)
Code List
Reason Treatment Ended (ORAL ANTIANDROGEN)
CL Item
Treatment Completed Per Protocol Criteria (Treatment completed per protocol criteria)
CL Item
Disease Progression, Relapse During Active Treatment (Disease progression, relapse during active treatment)
CL Item
Adverse Event/side Effects/complications (Adverse Event/Side Effects/Complications)
CL Item
Death On Study (Death on study)
CL Item
Patient Withdrawal Or Refusal After Beginning Protocol Therapy (Patient withdrawal/refusal after beginning protocol therapy)
CL Item
Patient Withdrawal Or Refusal Before Beginning Protocol Therapy (Patient withdrawal/refusal prior to beginning protocol therapy)
CL Item
Alternative Therapy (Alternative therapy)
CL Item
Patient Off-treatment For Other Complicating Disease (Patient off-treatment for other complicating disease)
CL Item
Other (Other)
C17649 (NCI Thesaurus)
C0205394 (UMLS 2011AA)
Off-treatmentAlternativeReasonSpecify
Item
Alternative Therapy, Specify
text
C25685 (NCI Thesaurus ValueDomain)
C1521902 (UMLS 2011AA ValueDomain)
C25601 (NCI Thesaurus ObjectClass)
C1518544 (UMLS 2011AA ObjectClass)
C25415 (NCI Thesaurus Property)
C1523987 (UMLS 2011AA Property)
C25365 (NCI Thesaurus Property-2)
C0678257 (UMLS 2011AA Property-2)
Off-TreatmentConditionSpecify
Item
Patient off-treatment for other complicating disease, specify
text
C25685 (NCI Thesaurus ValueDomain)
C1521902 (UMLS 2011AA ValueDomain)
C25601 (NCI Thesaurus ObjectClass)
C1518544 (UMLS 2011AA ObjectClass)
C25457 (NCI Thesaurus Property)
C0348080 (UMLS 2011AA Property)
Off Treatment Reason, specify
Item
Other specify
text
C25685 (NCI Thesaurus ValueDomain)
C1518544 (UMLS CUI-1)
C25601 (NCI Thesaurus ObjectClass)
C0566251 (UMLS CUI-2)
C25365 (NCI Thesaurus Property)
C1521902 (UMLS CUI-3)
Cumulative Dose Agent
Item
Total Dose (TO DATE)
float
C1708 (NCI Thesaurus ObjectClass)
C2986497 (UMLS CUI-1)
C25470 (NCI Thesaurus ObjectClass-2)
C1521826 (UMLS CUI-2)
C25304 (NCI Thesaurus Property)
C25256 (NCI Thesaurus Property-2)
C25304 (NCI Thesaurus ValueDomain)
C25488 (NCI Thesaurus ValueDomain-2)
Item Group
Treatment Schedule (oral Antiandrogen)
ProtocolHormoneTherapyPatientCurrentReceivedInd-3
Item
Is patient on protocol hormone (ORAL ANTIANDROGEN)
boolean
C16960 (NCI Thesaurus ObjectClass)
C0030705 (UMLS 2011AA ObjectClass)
C25320 (NCI Thesaurus ObjectClass-2)
C1507394 (UMLS 2011AA ObjectClass-2)
C15445 (NCI Thesaurus ObjectClass-3)
C0279025 (UMLS 2011AA ObjectClass-3)
C25471 (NCI Thesaurus Property)
C0521116 (UMLS 2011AA Property)
C25639 (NCI Thesaurus Property-2)
C1514756 (UMLS 2011AA Property-2)
C38148 (NCI Thesaurus ValueDomain)
C1512699 (UMLS 2011AA ValueDomain)
Item
Oral antiandrogen taken
text
C1708 (NCI Thesaurus ObjectClass)
C0450442 (UMLS 2011AA ObjectClass)
C25311 (NCI Thesaurus ObjectClass-2)
C0442027 (UMLS 2011AA ObjectClass-2)
C15481 (NCI Thesaurus ObjectClass-3)
C0279492 (UMLS 2011AA ObjectClass-3)
C25382 (NCI Thesaurus Property)
C1521801 (UMLS 2011AA Property)
C25191 (NCI Thesaurus ValueDomain)
C1547383 (UMLS 2011AA ValueDomain)
Code List
Oral antiandrogen taken
CL Item
Casodex (Casodex)
C0591237 (NCI Metathesaurus)
CL Item
Eulexin (Eulexin)
CL Item
Other (Other)
C17649 (NCI Thesaurus)
C0205394 (UMLS 2011AA)
OralAntiandrogenTherapyAgentAdministeredSpecify
Item
Other, specify
text
C1708 (NCI Thesaurus ObjectClass)
C0450442 (UMLS 2011AA ObjectClass)
C25311 (NCI Thesaurus ObjectClass-2)
C0442027 (UMLS 2011AA ObjectClass-2)
C15481 (NCI Thesaurus ObjectClass-3)
C0279492 (UMLS 2011AA ObjectClass-3)
C25382 (NCI Thesaurus Property)
C1521801 (UMLS 2011AA Property)
C25685 (NCI Thesaurus ValueDomain)
C1521902 (UMLS 2011AA ValueDomain)
OralAntiandrogenTherapyAgentAdministeredBeginDate
Item
Oral Antiandrogen Start Date (IF STARTED IN THIS FOLLOW-UP PERIOD)
date
C1708 (NCI Thesaurus ObjectClass)
C0450442 (UMLS 2011AA ObjectClass)
C25311 (NCI Thesaurus ObjectClass-2)
C0442027 (UMLS 2011AA ObjectClass-2)
C15481 (NCI Thesaurus ObjectClass-3)
C0279492 (UMLS 2011AA ObjectClass-3)
C25382 (NCI Thesaurus Property)
C1521801 (UMLS 2011AA Property)
C25164 (NCI Thesaurus ValueDomain)
C0011008 (UMLS 2011AA ValueDomain)
C25431 (NCI Thesaurus ValueDomain-2)
C0439659 (UMLS 2011AA ValueDomain-2)
OralAntiandrogenTherapyAgentAdministeredEndDate
Item
Oral Antiandrogen End Date (IF TERMINATED IN THIS FOLLOW-UP PERIOD)
date
C1708 (NCI Thesaurus ObjectClass)
C0450442 (UMLS 2011AA ObjectClass)
C25311 (NCI Thesaurus ObjectClass-2)
C0442027 (UMLS 2011AA ObjectClass-2)
C15481 (NCI Thesaurus ObjectClass-3)
C0279492 (UMLS 2011AA ObjectClass-3)
C25382 (NCI Thesaurus Property)
C1521801 (UMLS 2011AA Property)
C25164 (NCI Thesaurus ValueDomain)
C0011008 (UMLS 2011AA ValueDomain)
Item
Reason Treatment Ended (ORAL ANTIANDROGEN)
text
C25638 (NCI Thesaurus ValueDomain)
C1518544 (UMLS CUI-1)
C25601 (NCI Thesaurus ObjectClass)
C0566251 (UMLS CUI-2)
C25365 (NCI Thesaurus Property)
Code List
Reason Treatment Ended (ORAL ANTIANDROGEN)
CL Item
Treatment Completed Per Protocol Criteria (Treatment completed per protocol criteria)
CL Item
Disease Progression, Relapse During Active Treatment (Disease progression, relapse during active treatment)
CL Item
Adverse Event/side Effects/complications (Adverse Event/Side Effects/Complications)
CL Item
Death On Study (Death on study)
CL Item
Patient Withdrawal Or Refusal After Beginning Protocol Therapy (Patient withdrawal/refusal after beginning protocol therapy)
CL Item
Patient Withdrawal Or Refusal Before Beginning Protocol Therapy (Patient withdrawal/refusal prior to beginning protocol therapy)
CL Item
Alternative Therapy (Alternative therapy)
CL Item
Patient Off-treatment For Other Complicating Disease (Patient off-treatment for other complicating disease)
CL Item
Other (Other)
C17649 (NCI Thesaurus)
C0205394 (UMLS 2011AA)
Off-treatmentAlternativeReasonSpecify
Item
Alternative Therapy, Specify
text
C25685 (NCI Thesaurus ValueDomain)
C1521902 (UMLS 2011AA ValueDomain)
C25601 (NCI Thesaurus ObjectClass)
C1518544 (UMLS 2011AA ObjectClass)
C25415 (NCI Thesaurus Property)
C1523987 (UMLS 2011AA Property)
C25365 (NCI Thesaurus Property-2)
C0678257 (UMLS 2011AA Property-2)
Off-TreatmentConditionSpecify
Item
Patient off-treatment for other complicating disease, specify
text
C25685 (NCI Thesaurus ValueDomain)
C1521902 (UMLS 2011AA ValueDomain)
C25601 (NCI Thesaurus ObjectClass)
C1518544 (UMLS 2011AA ObjectClass)
C25457 (NCI Thesaurus Property)
C0348080 (UMLS 2011AA Property)
Off Treatment Reason, specify
Item
Other specify
text
C25685 (NCI Thesaurus ValueDomain)
C1518544 (UMLS CUI-1)
C25601 (NCI Thesaurus ObjectClass)
C0566251 (UMLS CUI-2)
C25365 (NCI Thesaurus Property)
C1521902 (UMLS CUI-3)
Cumulative Dose Agent
Item
Total Dose (TO DATE)
float
C1708 (NCI Thesaurus ObjectClass)
C2986497 (UMLS CUI-1)
C25470 (NCI Thesaurus ObjectClass-2)
C1521826 (UMLS CUI-2)
C25304 (NCI Thesaurus Property)
C25256 (NCI Thesaurus Property-2)
C25304 (NCI Thesaurus ValueDomain)
C25488 (NCI Thesaurus ValueDomain-2)
Item Group
Non-protocol Therapy
Item
Is the patient receiving any non-protocol cancer therapy not previously reported (PROSTATE If yes, enter therapy type and date for each therapy delivered during the follow-up period.)
text
C38148 (NCI Thesaurus ValueDomain)
C1512699 (UMLS 2011AA ValueDomain)
C15368 (NCI Thesaurus ObjectClass)
C25590 (NCI Thesaurus ObjectClass-2)
C1518384 (UMLS 2011AA ObjectClass)
C25382 (NCI Thesaurus Property)
C1521801 (UMLS 2011AA Property)
Code List
Is the patient receiving any non-protocol cancer therapy not previously reported (PROSTATE If yes, enter therapy type and date for each therapy delivered during the follow-up period.)
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Item
Non-Protocol Therapy Type
text
C25284 (NCI Thesaurus ValueDomain)
C0332307 (UMLS 2011AA ValueDomain)
C15368 (NCI Thesaurus ObjectClass)
C25590 (NCI Thesaurus ObjectClass-2)
C1518384 (UMLS 2011AA ObjectClass)
C25382 (NCI Thesaurus Property)
C1521801 (UMLS 2011AA Property)
Code List
Non-Protocol Therapy Type
CL Item
Radiation To Pelvis (Radiation to pelvis)
CL Item
Radiation To Other Sites, Specify (Radiation to other sites)
CL Item
Surgery (Surgery)
C17173 (NCI Thesaurus)
C0038894 (UMLS 2011AA)
CL Item
Chemotherapy (Chemotherapy)
C15632 (NCI Thesaurus)
C0392920 (UMLS 2011AA)
CL Item
Hormones (Hormones)
CL Item
Other Specify (Other)
Non-ProtocolTherapyFirstAdministeredDate
Item
Date of First Non-Protocol Therapy
date
C15368 (NCI Thesaurus ObjectClass)
C25590 (NCI Thesaurus ObjectClass-2)
C1518384 (UMLS 2011AA ObjectClass)
C25509 (NCI Thesaurus Property)
C1279901 (UMLS 2011AA Property)
C25382 (NCI Thesaurus Property-2)
C1521801 (UMLS 2011AA Property-2)
C25164 (NCI Thesaurus ValueDomain)
C0011008 (UMLS 2011AA ValueDomain)
C25367 (NCI Thesaurus ValueDomain-2)
Non-ProtocolTreatmentFirstAdministeredSpecify
Item
Specify
text
C15368 (NCI Thesaurus ObjectClass)
C25590 (NCI Thesaurus ObjectClass-2)
C1518384 (UMLS 2011AA ObjectClass)
C25509 (NCI Thesaurus Property)
C1279901 (UMLS 2011AA Property)
C25382 (NCI Thesaurus Property-2)
C1521801 (UMLS 2011AA Property-2)
C25685 (NCI Thesaurus ValueDomain)
C1521902 (UMLS 2011AA ValueDomain)
Item Group
Unnamed Module 7
Item
Has a new primary cancer or MDS been diagnosed that has not been previously reported? (MYELODYSPLASTIC SYNDROME)
text
C38148 (NCI Thesaurus ValueDomain)
C1512699 (UMLS 2011AA ValueDomain)
C25586 (NCI Thesaurus ObjectClass)
C0205314 (UMLS 2011AA ObjectClass)
C9305 (NCI Thesaurus ObjectClass-2)
C0006826 (UMLS 2011AA ObjectClass-2)
C15220 (NCI Thesaurus Property)
C0011900 (UMLS 2011AA Property)
Code List
Has a new primary cancer or MDS been diagnosed that has not been previously reported? (MYELODYSPLASTIC SYNDROME)
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Item
Second Primary Tumor Site
text
C13717 (NCI Thesaurus ValueDomain)
C0751623 (UMLS CUI-1)
C3262 (NCI Thesaurus ObjectClass)
C1515974 (UMLS CUI-2)
C25341 (NCI Thesaurus Property)
C25666 (NCI Thesaurus ObjectClass-2)
Code List
Second Primary Tumor Site
CL Item
Aml/mds (AML/MDS)
C9441 (NCI Thesaurus)
CL Item
Bcc (BCC)
CL Item
Bladder Is The Site Of Second Primary Or Recurrent Tumor (bladder)
CL Item
Brain Is The Site Of Second Primary Or Recurrent Tumor (brain)
CL Item
Colorectal (Colorectal)
C13363 (NCI Thesaurus)
C0555952 (UMLS 2011AA)
CL Item
Esophageal (Esophageal)
C37950 (NCI Thesaurus)
C1522619 (UMLS 2011AA)
CL Item
Gastric (Gastric)
C13307 (NCI Thesaurus)
C1704242 (UMLS 2011AA)
CL Item
Liver Is The Site Of Second Primary Or Recurrent Tumor (liver)
CL Item
Lung Is The Site Of Second Primary Or Recurrent Tumor (lung)
CL Item
Melanoma (Melanoma)
C3224 (NCI Thesaurus)
C0025202 (UMLS 2011AA)
CL Item
Nhl (NHL)
CL Item
Pancreatic (Pancreatic)
C25726 (NCI Thesaurus)
C0030274 (UMLS 2011AA)
CL Item
Renal (Renal)
C25225 (NCI Thesaurus)
C0022646 (UMLS 2011AA)
CL Item
Squamous-skin (Squamous-skin)
CL Item
Other Hematologic (Other hematologic)
CL Item
Other Solid (Other solid)
CL Item
Unknown Primary (Unknown primary)
Second Primary Tumor Date
Item
Second Primary Cancer Date
date
C3262 (NCI Thesaurus ObjectClass)
C0751623 (UMLS CUI-1)
C25251 (NCI Thesaurus ObjectClass-2)
C0011008 (UMLS CUI-2)
C25666 (NCI Thesaurus ObjectClass-3)
C15220 (NCI Thesaurus Property)
C25164 (NCI Thesaurus ValueDomain)
Primary Disease Site
Item
Other specify
text
C25685 (NCI Thesaurus ValueDomain)
C0449695 (UMLS CUI-1)
C25341 (NCI Thesaurus Property)
C25251 (NCI Thesaurus ObjectClass)
C2991 (NCI Thesaurus ObjectClass-2)
Item Group
Baseline Lab Values (hematologic)
Laboratory Procedure Date
Item
Date (s)
date
C25164 (NCI Thesaurus ValueDomain)
C0022885 (UMLS CUI-1)
C25214 (NCI Thesaurus Property)
C0011008 (UMLS CUI-2)
C38000 (NCI Thesaurus Property-2)
C25294 (NCI Thesaurus ObjectClass)
Laboratory Procedure Date
Item
Date (s)
date
C25164 (NCI Thesaurus ValueDomain)
C0022885 (UMLS CUI-1)
C25214 (NCI Thesaurus Property)
C0011008 (UMLS CUI-2)
C38000 (NCI Thesaurus Property-2)
C25294 (NCI Thesaurus ObjectClass)
Laboratory Procedure Date
Item
Date (s)
date
C25164 (NCI Thesaurus ValueDomain)
C0022885 (UMLS CUI-1)
C25214 (NCI Thesaurus Property)
C0011008 (UMLS CUI-2)
C38000 (NCI Thesaurus Property-2)
C25294 (NCI Thesaurus ObjectClass)
Laboratory Procedure Date
Item
Date (s)
date
C25164 (NCI Thesaurus ValueDomain)
C0022885 (UMLS CUI-1)
C25214 (NCI Thesaurus Property)
C0011008 (UMLS CUI-2)
C38000 (NCI Thesaurus Property-2)
C25294 (NCI Thesaurus ObjectClass)
Leukocytes (WBC)
Item
WBC (mm^3)
float
C25294 (NCI Thesaurus ObjectClass)
C0023508 (UMLS CUI-1)
C12529 (NCI Thesaurus Property)
C20200 (NCI Thesaurus Property-2)
C38046 (NCI Thesaurus ValueDomain)
C25712 (NCI Thesaurus ValueDomain-2)
Hemoglobin
Item
Hemoglobin (g/dL)
float
C16676 (NCI Thesaurus Property)
C0019046 (UMLS CUI-1)
C20200 (NCI Thesaurus Property-2)
C25294 (NCI Thesaurus ObjectClass)
C25712 (NCI Thesaurus ValueDomain)
Platelets
Item
Peripheral Platelet Count (mm^3)
float
C20200 (NCI Thesaurus Property)
C0005821 (UMLS CUI-1)
C12520 (NCI Thesaurus Property-2)
C25294 (NCI Thesaurus ObjectClass)
C25712 (NCI Thesaurus ValueDomain)
Neutrophil count
Item
ANC (mm^3)
float
C25294 (NCI Thesaurus ObjectClass)
C0200633 (UMLS CUI-1)
C12533 (NCI Thesaurus Property)
C20200 (NCI Thesaurus Property-2)
C25304 (NCI Thesaurus ValueDomain)
C25712 (NCI Thesaurus ValueDomain-2)
Item Group
Protocol Specific Adverse Event Evaluation
Item
Any Treatment Related Adverse Events
text
C25648 (NCI Thesaurus ObjectClass)
C0877248 (UMLS CUI-1)
C41331 (NCI Thesaurus ObjectClass-2)
C15368 (NCI Thesaurus ObjectClass-3)
C0684224 (NCI Metathesaurus Property)
C38148 (NCI Thesaurus ValueDomain)
Code List
Any Treatment Related Adverse Events
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Primary Site MedDRA Code
Item
MedDRA Disease Code
float
C41331 (NCI Thesaurus ObjectClass)
C0449695 (UMLS CUI-1)
C71886 (NCI Thesaurus ObjectClass-2)
C1552878 (UMLS CUI-2)
C25162 (NCI Thesaurus Property)
C43820 (NCI Thesaurus Property-2)
C25162 (NCI Thesaurus ValueDomain)
C41331 (NCI Thesaurus ValueDomain-2)
C45255 (NCI Thesaurus ValueDomain-3)
C43820 (NCI Thesaurus ValueDomain-4)
C25714 (NCI Thesaurus ValueDomain-5)
Item
CTC Adverse Event Term (OTHER CTC ADVERSE EVENT NOT LISTED)
text
C41331 (NCI Thesaurus ObjectClass)
C0877248 (UMLS 2011AA ObjectClass)
C49704 (NCI Thesaurus Property)
C1516728 (UMLS 2011AA Property)
C45559 (NCI Thesaurus Property-2)
C1705313 (UMLS 2011AA Property-2)
C45255 (NCI Thesaurus ValueDomain)
C1708523 (UMLS 2011AA ValueDomain)
C49704 (NCI Thesaurus ValueDomain-2)
C1516728 (UMLS 2011AA ValueDomain-2)
C42614 (NCI Thesaurus ValueDomain-3)
C0027365 (UMLS 2011AA ValueDomain-3)
C45559 (NCI Thesaurus ValueDomain-4)
C1705313 (UMLS 2011AA ValueDomain-4)
C25714 (NCI Thesaurus ValueDomain-5)
C0333052 (UMLS 2011AA ValueDomain-5)
Code List
CTC Adverse Event Term (OTHER CTC ADVERSE EVENT NOT LISTED)
CL Item
Abdominal Distension (Abdominal distension)
E10456 (CTCAE)
CL Item
Abdominal Infection (Abdominal infection)
E11282 (CTCAE)
CL Item
Abdominal Pain (Abdominal pain)
E10460 (CTCAE)
CL Item
Abdominal Soft Tissue Necrosis (Abdominal soft tissue necrosis)
E12369 (CTCAE)
CL Item
Abducens Nerve Disorder (Abducens nerve disorder)
E12569 (CTCAE)
CL Item
Accessory Nerve Disorder (Accessory nerve disorder)
E12573 (CTCAE)
CL Item
Acidosis (Acidosis)
E12237 (CTCAE)
CL Item
Acoustic Nerve Disorder Nos (Acoustic nerve disorder NOS)
E12577 (CTCAE)
CL Item
Activated Partial Thromboplastin Time Prolonged (Activated partial thromboplastin time prolonged)
E12073 (CTCAE)
CL Item
Acute Coronary Syndrome (Acute coronary syndrome)
E10066 (CTCAE)
CL Item
Acute Kidney Injury (Acute kidney injury)
E12973 (CTCAE)
CL Item
Adrenal Insufficiency (Adrenal insufficiency)
E10298 (CTCAE)
CL Item
Adult Respiratory Distress Syndrome (Adult respiratory distress syndrome)
E13299 (CTCAE)
CL Item
Agitation (Agitation)
E12874 (CTCAE)
CL Item
Akathisia (Akathisia)
E12581 (CTCAE)
CL Item
Alanine Aminotransferase Increased (Alanine aminotransferase increased)
E12077 (CTCAE)
CL Item
Alcohol Intolerance (Alcohol intolerance)
E12242 (CTCAE)
CL Item
Alkaline Phosphatase Increased (Alkaline phosphatase increased)
E12082 (CTCAE)
CL Item
Alkalosis (Alkalosis)
E12247 (CTCAE)
CL Item
Allergic Reaction (Allergic reaction)
E11248 (CTCAE)
CL Item
Allergic Rhinitis (Allergic rhinitis)
E13303 (CTCAE)
CL Item
Alopecia (Alopecia)
E13611 (CTCAE)
CL Item
Amnesia (Amnesia)
E12585 (CTCAE)
CL Item
Anal Fistula (Anal fistula)
E10464 (CTCAE)
CL Item
Anal Hemorrhage (Anal hemorrhage)
E10470 (CTCAE)
CL Item
Anal Mucositis (Anal mucositis)
E10476 (CTCAE)
CL Item
Anal Necrosis (Anal necrosis)
E10482 (CTCAE)
CL Item
Anal Pain (Anal pain)
E10486 (CTCAE)
CL Item
Anal Stenosis (Anal stenosis)
E10490 (CTCAE)
CL Item
Anal Ulcer (Anal ulcer)
E10496 (CTCAE)
CL Item
Anaphylaxis (Anaphylaxis)
E11254 (CTCAE)
CL Item
Anemia (Anemia)
E10010 (CTCAE)
CL Item
Ankle Fracture (Ankle fracture)
E11640 (CTCAE)
CL Item
Anorectal Infection (Anorectal infection)
E11286 (CTCAE)
CL Item
Anorexia (Anorexia)
E12252 (CTCAE)
CL Item
Anorgasmia (Anorgasmia)
E12880 (CTCAE)
CL Item
Anxiety (Anxiety)
E12883 (CTCAE)
CL Item
Aortic Injury (Aortic injury)
E11644 (CTCAE)
CL Item
Aortic Valve Disease (Aortic valve disease)
E10071 (CTCAE)
CL Item
Aphonia (Aphonia)
E12589 (CTCAE)
CL Item
Apnea (Apnea)
E13306 (CTCAE)
CL Item
Appendicitis (Appendicitis)
E11292 (CTCAE)
CL Item
Appendicitis Perforated (Appendicitis perforated)
E11296 (CTCAE)
CL Item
Arachnoiditis (Arachnoiditis)
E12591 (CTCAE)
CL Item
Arterial Injury (Arterial injury)
E11648 (CTCAE)
CL Item
Arteritis Infective (Arteritis infective)
E11301 (CTCAE)
CL Item
Arthralgia (Arthralgia)
E12374 (CTCAE)
CL Item
Arthritis (Arthritis)
E12378 (CTCAE)
CL Item
Ascites (Ascites)
E10502 (CTCAE)
CL Item
Aspartate Aminotransferase Increased (Aspartate aminotransferase increased)
E12087 (CTCAE)
CL Item
Aspiration (Aspiration)
E13310 (CTCAE)
CL Item
Asystole (Asystole)
E10077 (CTCAE)
CL Item
Ataxia (Ataxia)
E12597 (CTCAE)
CL Item
Atelectasis (Atelectasis)
E13316 (CTCAE)
CL Item
Atrial Fibrillation (Atrial fibrillation)
E10081 (CTCAE)
CL Item
Atrial Flutter (Atrial flutter)
E10087 (CTCAE)
CL Item
Atrioventricular Block Complete (Atrioventricular block complete)
E10093 (CTCAE)
CL Item
Atrioventricular Block First Degree (Atrioventricular block first degree)
E10098 (CTCAE)
CL Item
Autoimmune Disorder (Autoimmune disorder)
E11258 (CTCAE)
CL Item
Avascular Necrosis (Avascular necrosis)
E12382 (CTCAE)
CL Item
Azoospermia (Azoospermia)
E13067 (CTCAE)
CL Item
Back Pain (Back pain)
E12388 (CTCAE)
CL Item
Bile Duct Stenosis (Bile duct stenosis)
E11173 (CTCAE)
CL Item
Biliary Anastomotic Leak (Biliary anastomotic leak)
E11654 (CTCAE)
CL Item
Biliary Fistula (Biliary fistula)
E11179 (CTCAE)
CL Item
Biliary Tract Infection (Biliary tract infection)
E11305 (CTCAE)
CL Item
Bladder Anastomotic Leak (Bladder anastomotic leak)
E11660 (CTCAE)
CL Item
Bladder Infection (Bladder infection)
E11309 (CTCAE)
CL Item
Bladder Perforation (Bladder perforation)
E12979 (CTCAE)
CL Item
Bladder Spasm (Bladder spasm)
E12984 (CTCAE)
CL Item
Bloating (Bloating)
E10508 (CTCAE)
CL Item
Blood And Lymphatic System Disorders - Other, Specify (Blood and lymphatic system disorders - Other, Specify)
E10016 (CTCAE)
CL Item
Blood Antidiuretic Hormone Abnormal (Blood antidiuretic hormone abnormal)
E12092 (CTCAE)
CL Item
Blood Bilirubin Increased (Blood bilirubin increased)
E12096 (CTCAE)
CL Item
Blood Corticotrophin Decreased (Blood corticotrophin decreased)
E12101 (CTCAE)
CL Item
Blood Gonadotrophin Abnormal (Blood gonadotrophin abnormal)
E12105 (CTCAE)
CL Item
Blood Prolactin Abnormal (Blood prolactin abnormal)
E12109 (CTCAE)
CL Item
Blurred Vision (Blurred vision)
E10346 (CTCAE)
CL Item
Body Odor (Body odor)
E13614 (CTCAE)
CL Item
Bone Infection (Bone infection)
E11314 (CTCAE)
CL Item
Bone Marrow Hypocellular (Bone marrow hypocellular)
E10022 (CTCAE)
CL Item
Bone Pain (Bone pain)
E12392 (CTCAE)
CL Item
Brachial Plexopathy (Brachial plexopathy)
E12601 (CTCAE)
CL Item
Breast Atrophy (Breast atrophy)
E13069 (CTCAE)
CL Item
Breast Infection (Breast infection)
E11318 (CTCAE)
CL Item
Breast Pain (Breast pain)
E13073 (CTCAE)
CL Item
Bronchial Fistula (Bronchial fistula)
E13322 (CTCAE)
CL Item
Bronchial Infection (Bronchial infection)
E11323 (CTCAE)
CL Item
Bronchial Obstruction (Bronchial obstruction)
E13328 (CTCAE)
CL Item
Bronchial Stricture (Bronchial stricture)
E13334 (CTCAE)
CL Item
Bronchopleural Fistula (Bronchopleural fistula)
E13340 (CTCAE)
CL Item
Bronchopulmonary Hemorrhage (Bronchopulmonary hemorrhage)
E13346 (CTCAE)
CL Item
Bronchospasm (Bronchospasm)
E13352 (CTCAE)
CL Item
Bruising (Bruising)
E11666 (CTCAE)
CL Item
Bullous Dermatitis (Bullous dermatitis)
E13617 (CTCAE)
CL Item
Burn (Burn)
E11669 (CTCAE)
CL Item
Buttock Pain (Buttock pain)
E12396 (CTCAE)
CL Item
Capillary Leak Syndrome (Capillary leak syndrome)
E13766 (CTCAE)
CL Item
Carbon Monoxide Diffusing Capacity Decreased (Carbon monoxide diffusing capacity decreased)
E12112 (CTCAE)
CL Item
Cardiac Arrest (Cardiac arrest)
E10101 (CTCAE)
CL Item
Cardiac Disorders - Other, Specify (Cardiac disorders - Other, Specify)
E10104 (CTCAE)
CL Item
Cardiac Troponin I Increased (Cardiac troponin I increased)
E12116 (CTCAE)
CL Item
Cardiac Troponin T Increased (Cardiac troponin T increased)
E12119 (CTCAE)
CL Item
Cataract (Cataract)
E10350 (CTCAE)
CL Item
Catheter Related Infection (Catheter related infection)
E11328 (CTCAE)
CL Item
Cd4 Lymphocytes Decreased (CD4 lymphocytes decreased)
E12122 (CTCAE)
CL Item
Cecal Hemorrhage (Cecal hemorrhage)
E10511 (CTCAE)
CL Item
Cecal Infection (Cecal infection)
E11333 (CTCAE)
CL Item
Central Nervous System Necrosis (Central nervous system necrosis)
E12605 (CTCAE)
CL Item
Cerebrospinal Fluid Leakage (Cerebrospinal fluid leakage)
E12611 (CTCAE)
CL Item
Cervicitis Infection (Cervicitis infection)
E11337 (CTCAE)
CL Item
Cheilitis (Cheilitis)
E10517 (CTCAE)
CL Item
Chest Pain - Cardiac (Chest pain - cardiac)
E10110 (CTCAE)
CL Item
Chest Wall Pain (Chest wall pain)
E12400 (CTCAE)
CL Item
Chills (Chills)
E11074 (CTCAE)
CL Item
Cholecystitis (Cholecystitis)
E11184 (CTCAE)
CL Item
Cholesterol High (Cholesterol high)
E12127 (CTCAE)
CL Item
Chronic Kidney Disease (Chronic kidney disease)
E12988 (CTCAE)
CL Item
Chylothorax (Chylothorax)
E13358 (CTCAE)
CL Item
Cognitive Disturbance (Cognitive disturbance)
E12617 (CTCAE)
CL Item
Colitis (Colitis)
E10521 (CTCAE)
CL Item
Colonic Fistula (Colonic fistula)
E10527 (CTCAE)
CL Item
Colonic Hemorrhage (Colonic hemorrhage)
E10533 (CTCAE)
CL Item
Colonic Obstruction (Colonic obstruction)
E10539 (CTCAE)
CL Item
Colonic Perforation (Colonic perforation)
E10545 (CTCAE)
CL Item
Colonic Stenosis (Colonic stenosis)
E10550 (CTCAE)
CL Item
Colonic Ulcer (Colonic ulcer)
E10556 (CTCAE)
CL Item
Concentration Impairment (Concentration impairment)
E12621 (CTCAE)
CL Item
Conduction Disorder (Conduction disorder)
E10114 (CTCAE)
CL Item
Confusion (Confusion)
E12889 (CTCAE)
CL Item
Congenital, Familial And Genetic Disorders - Other, Specify (Congenital, familial and genetic disorders - Other, Specify)
E10250 (CTCAE)
CL Item
Conjunctivitis (Conjunctivitis)
E10355 (CTCAE)
CL Item
Conjunctivitis Infective (Conjunctivitis infective)
E11342 (CTCAE)
CL Item
Constipation (Constipation)
E10562 (CTCAE)
CL Item
Constrictive Pericarditis (Constrictive pericarditis)
E10120 (CTCAE)
CL Item
Corneal Infection (Corneal infection)
E11347 (CTCAE)
CL Item
Corneal Ulcer (Corneal ulcer)
E10359 (CTCAE)
CL Item
Cough (Cough)
E13364 (CTCAE)
CL Item
Cpk Increased (CPK increased)
E12132 (CTCAE)
CL Item
Cranial Nerve Infection (Cranial nerve infection)
E11352 (CTCAE)
CL Item
Creatinine Increased (Creatinine increased)
E12137 (CTCAE)
CL Item
Cushingoid (Cushingoid)
E10304 (CTCAE)
CL Item
Cystitis Noninfective (Cystitis noninfective)
E12994 (CTCAE)
CL Item
Cytokine Release Syndrome (Cytokine release syndrome)
E11264 (CTCAE)
CL Item
Death Neonatal (Death neonatal)
E11078 (CTCAE)
CL Item
Death Nos (Death NOS)
E11080 (CTCAE)
CL Item
Dehydration (Dehydration)
E12258 (CTCAE)
CL Item
Delayed Orgasm (Delayed orgasm)
E12895 (CTCAE)
CL Item
Delayed Puberty (Delayed puberty)
E10308 (CTCAE)
CL Item
Delirium (Delirium)
E12898 (CTCAE)
CL Item
Delusions (Delusions)
E12904 (CTCAE)
CL Item
Dental Caries (Dental caries)
E10568 (CTCAE)
CL Item
Depressed Level Of Consciousness (Depressed level of consciousness)
E12625 (CTCAE)
CL Item
Depression (Depression)
E12909 (CTCAE)
CL Item
Dermatitis Radiation (Dermatitis radiation)
E11675 (CTCAE)
CL Item
Device Related Infection (Device related infection)
E11356 (CTCAE)
CL Item
Diarrhea (Diarrhea)
E10572 (CTCAE)
CL Item
Disseminated Intravascular Coagulation (Disseminated intravascular coagulation)
E10028 (CTCAE)
CL Item
Dizziness (Dizziness)
E12631 (CTCAE)
CL Item
Dry Eye (Dry eye)
E10363 (CTCAE)
CL Item
Dry Mouth (Dry mouth)
E10578 (CTCAE)
CL Item
Dry Skin (Dry skin)
E13623 (CTCAE)
CL Item
Duodenal Fistula (Duodenal fistula)
E10582 (CTCAE)
CL Item
Duodenal Hemorrhage (Duodenal hemorrhage)
E10588 (CTCAE)
CL Item
Duodenal Infection (Duodenal infection)
E11360 (CTCAE)
CL Item
Duodenal Obstruction (Duodenal obstruction)
E10594 (CTCAE)
CL Item
Duodenal Perforation (Duodenal perforation)
E10600 (CTCAE)
CL Item
Duodenal Stenosis (Duodenal stenosis)
E10605 (CTCAE)
CL Item
Duodenal Ulcer (Duodenal ulcer)
E10611 (CTCAE)
CL Item
Dysarthria (Dysarthria)
E12635 (CTCAE)
CL Item
Dysesthesia (Dysesthesia)
E12639 (CTCAE)
CL Item
Dysgeusia (Dysgeusia)
E12643 (CTCAE)
CL Item
Dysmenorrhea (Dysmenorrhea)
E13077 (CTCAE)
CL Item
Dyspareunia (Dyspareunia)
E13081 (CTCAE)
CL Item
Dyspepsia (Dyspepsia)
E10617 (CTCAE)
CL Item
Dysphagia (Dysphagia)
E10621 (CTCAE)
CL Item
Dysphasia (Dysphasia)
E12646 (CTCAE)
CL Item
Dyspnea (Dyspnea)
E13368 (CTCAE)
CL Item
Ear And Labyrinth Disorders - Other, Specify (Ear and labyrinth disorders - Other, Specify)
E10256 (CTCAE)
CL Item
Ear Pain (Ear pain)
E10262 (CTCAE)
CL Item
Edema Cerebral (Edema cerebral)
E12650 (CTCAE)
CL Item
Edema Face (Edema face)
E11082 (CTCAE)
CL Item
Edema Limbs (Edema limbs)
E11086 (CTCAE)
CL Item
Edema Trunk (Edema trunk)
E11090 (CTCAE)
CL Item
Ejaculation Disorder (Ejaculation disorder)
E13085 (CTCAE)
CL Item
Ejection Fraction Decreased (Ejection fraction decreased)
E12142 (CTCAE)
CL Item
Electrocardiogram Qt Corrected Interval Prolonged (Electrocardiogram QT corrected interval prolonged)
E12146 (CTCAE)
CL Item
Encephalitis Infection (Encephalitis infection)
E11365 (CTCAE)
CL Item
Encephalomyelitis Infection (Encephalomyelitis infection)
E11369 (CTCAE)
CL Item
Encephalopathy (Encephalopathy)
E12652 (CTCAE)
CL Item
Endocarditis Infective (Endocarditis infective)
E11373 (CTCAE)
CL Item
Endocrine Disorders - Other, Specify (Endocrine disorders - Other, Specify)
E10311 (CTCAE)
CL Item
Endophthalmitis (Endophthalmitis)
E11377 (CTCAE)
CL Item
Enterocolitis (Enterocolitis)
E10627 (CTCAE)
CL Item
Enterocolitis Infectious (Enterocolitis infectious)
E11381 (CTCAE)
CL Item
Enterovesical Fistula (Enterovesical fistula)
E10633 (CTCAE)
CL Item
Epistaxis (Epistaxis)
E13374 (CTCAE)
CL Item
Erectile Dysfunction (Erectile dysfunction)
E13088 (CTCAE)
CL Item
Erythema Multiforme (Erythema multiforme)
E13627 (CTCAE)
CL Item
Erythroderma (Erythroderma)
E13633 (CTCAE)
CL Item
Esophageal Anastomotic Leak (Esophageal anastomotic leak)
E11681 (CTCAE)
CL Item
Esophageal Fistula (Esophageal fistula)
E10639 (CTCAE)
CL Item
Esophageal Hemorrhage (Esophageal hemorrhage)
E10645 (CTCAE)
CL Item
Esophageal Infection (Esophageal infection)
E11386 (CTCAE)
CL Item
Esophageal Necrosis (Esophageal necrosis)
E10651 (CTCAE)
CL Item
Esophageal Obstruction (Esophageal obstruction)
E10655 (CTCAE)
CL Item
Esophageal Pain (Esophageal pain)
E10661 (CTCAE)
CL Item
Esophageal Perforation (Esophageal perforation)
E10665 (CTCAE)
CL Item
Esophageal Stenosis (Esophageal stenosis)
E10670 (CTCAE)
CL Item
Esophageal Ulcer (Esophageal ulcer)
E10676 (CTCAE)
CL Item
Esophageal Varices Hemorrhage (Esophageal varices hemorrhage)
E10682 (CTCAE)
CL Item
Esophagitis (Esophagitis)
E10687 (CTCAE)
CL Item
Euphoria (Euphoria)
E12915 (CTCAE)
CL Item
Exostosis (Exostosis)
E12404 (CTCAE)
CL Item
External Ear Inflammation (External ear inflammation)
E10266 (CTCAE)
CL Item
External Ear Pain (External ear pain)
E10272 (CTCAE)
CL Item
Extraocular Muscle Paresis (Extraocular muscle paresis)
E10367 (CTCAE)
CL Item
Extrapyramidal Disorder (Extrapyramidal disorder)
E12658 (CTCAE)
CL Item
Eye Disorders - Other, Specify (Eye disorders - Other, Specify)
E10371 (CTCAE)
CL Item
Eye Infection (Eye infection)
E11391 (CTCAE)
CL Item
Eye Pain (Eye pain)
E10376 (CTCAE)
CL Item
Eyelid Function Disorder (Eyelid function disorder)
E10380 (CTCAE)
CL Item
Facial Muscle Weakness (Facial muscle weakness)
E12664 (CTCAE)
CL Item
Facial Nerve Disorder (Facial nerve disorder)
E12668 (CTCAE)
CL Item
Facial Pain (Facial pain)
E11094 (CTCAE)
CL Item
Fall (Fall)
E11687 (CTCAE)
CL Item
Fallopian Tube Anastomotic Leak (Fallopian tube anastomotic leak)
E11691 (CTCAE)
CL Item
Fallopian Tube Obstruction (Fallopian tube obstruction)
E13092 (CTCAE)
CL Item
Fallopian Tube Perforation (Fallopian tube perforation)
E11697 (CTCAE)
CL Item
Fallopian Tube Stenosis (Fallopian tube stenosis)
E13096 (CTCAE)
CL Item
Fat Atrophy (Fat atrophy)
E13638 (CTCAE)
CL Item
Fatigue (Fatigue)
E11098 (CTCAE)
CL Item
Febrile Neutropenia (Febrile neutropenia)
E10033 (CTCAE)
CL Item
Fecal Incontinence (Fecal incontinence)
E10693 (CTCAE)
CL Item
Female Genital Tract Fistula (Female genital tract fistula)
E13102 (CTCAE)
CL Item
Feminization Acquired (Feminization acquired)
E13108 (CTCAE)
CL Item
Fetal Death (Fetal death)
E12855 (CTCAE)
CL Item
Fetal Growth Retardation (Fetal growth retardation)
E12857 (CTCAE)
CL Item
Fever (Fever)
E11102 (CTCAE)
CL Item
Fibrinogen Decreased (Fibrinogen decreased)
E12151 (CTCAE)
CL Item
Fibrosis Deep Connective Tissue (Fibrosis deep connective tissue)
E12408 (CTCAE)
CL Item
Flank Pain (Flank pain)
E12414 (CTCAE)
CL Item
Flashing Lights (Flashing lights)
E10384 (CTCAE)
CL Item
Flatulence (Flatulence)
E10697 (CTCAE)
CL Item
Floaters (Floaters)
E10388 (CTCAE)
CL Item
Flu Like Symptoms (Flu like symptoms)
E11108 (CTCAE)
CL Item
Flushing (Flushing)
E13771 (CTCAE)
CL Item
Forced Expiratory Volume Decreased (Forced expiratory volume decreased)
E12156 (CTCAE)
CL Item
Fracture (Fracture)
E11703 (CTCAE)
CL Item
Gait Disturbance (Gait disturbance)
E11112 (CTCAE)
CL Item
Gallbladder Fistula (Gallbladder fistula)
E11189 (CTCAE)
CL Item
Gallbladder Infection (Gallbladder infection)
E11396 (CTCAE)
CL Item
Gallbladder Necrosis (Gallbladder necrosis)
E11195 (CTCAE)
CL Item
Gallbladder Obstruction (Gallbladder obstruction)
E11198 (CTCAE)
CL Item
Gallbladder Pain (Gallbladder pain)
E11204 (CTCAE)
CL Item
Gallbladder Perforation (Gallbladder perforation)
E11208 (CTCAE)
CL Item
Gastric Anastomotic Leak (Gastric anastomotic leak)
E11709 (CTCAE)
CL Item
Gastric Fistula (Gastric fistula)
E10700 (CTCAE)
CL Item
Gastric Hemorrhage (Gastric hemorrhage)
E10706 (CTCAE)
CL Item
Gastric Necrosis (Gastric necrosis)
E10712 (CTCAE)
CL Item
Gastric Perforation (Gastric perforation)
E10716 (CTCAE)
CL Item
Gastric Stenosis (Gastric stenosis)
E10721 (CTCAE)
CL Item
Gastric Ulcer (Gastric ulcer)
E10727 (CTCAE)
CL Item
Gastritis (Gastritis)
E10733 (CTCAE)
CL Item
Gastroesophageal Reflux Disease (Gastroesophageal reflux disease)
E10739 (CTCAE)
CL Item
Gastrointestinal Anastomotic Leak (Gastrointestinal anastomotic leak)
E11715 (CTCAE)
CL Item
Gastrointestinal Disorders - Other, Specify (Gastrointestinal disorders - Other, Specify)
E10743 (CTCAE)
CL Item
Gastrointestinal Fistula (Gastrointestinal fistula)
E10749 (CTCAE)
CL Item
Gastrointestinal Pain (Gastrointestinal pain)
E10755 (CTCAE)
CL Item
Gastrointestinal Stoma Necrosis (Gastrointestinal stoma necrosis)
E11721 (CTCAE)
CL Item
Gastroparesis (Gastroparesis)
E10759 (CTCAE)
CL Item
General Disorders And Administration Site Conditions - Other, Specify (General disorders and administration site conditions - Other, Specify)
E11116 (CTCAE)
CL Item
Generalized Muscle Weakness (Generalized muscle weakness)
E12418 (CTCAE)
CL Item
Genital Edema (Genital edema)
E13111 (CTCAE)
CL Item
Ggt Increased (GGT increased)
E12161 (CTCAE)
CL Item
Gingival Pain (Gingival pain)
E10763 (CTCAE)
CL Item
Glaucoma (Glaucoma)
E10392 (CTCAE)
CL Item
Glossopharyngeal Nerve Disorder (Glossopharyngeal nerve disorder)
E12672 (CTCAE)
CL Item
Glucose Intolerance (Glucose intolerance)
E12264 (CTCAE)
CL Item
Growth Accelerated (Growth accelerated)
E10317 (CTCAE)
CL Item
Growth Hormone Abnormal (Growth hormone abnormal)
E12166 (CTCAE)
CL Item
Growth Suppression (Growth suppression)
E12422 (CTCAE)
CL Item
Gum Infection (Gum infection)
E11400 (CTCAE)
CL Item
Gynecomastia (Gynecomastia)
E13115 (CTCAE)
CL Item
Hallucinations (Hallucinations)
E12919 (CTCAE)
CL Item
Haptoglobin Decreased (Haptoglobin decreased)
E12169 (CTCAE)
CL Item
Head Soft Tissue Necrosis (Head soft tissue necrosis)
E12426 (CTCAE)
CL Item
Headache (Headache)
E12678 (CTCAE)
CL Item
Hearing Impaired (Hearing impaired)
E10276 (CTCAE)
CL Item
Heart Failure (Heart failure)
E10124 (CTCAE)
CL Item
Hematoma (Hematoma)
E13775 (CTCAE)
CL Item
Hematosalpinx (Hematosalpinx)
E13119 (CTCAE)
CL Item
Hematuria (Hematuria)
E13000 (CTCAE)
CL Item
Hemoglobin Increased (Hemoglobin increased)
E12171 (CTCAE)
CL Item
Hemoglobinuria (Hemoglobinuria)
E13006 (CTCAE)
CL Item
Hemolysis (Hemolysis)
E10037 (CTCAE)
CL Item
Hemolytic Uremic Syndrome (Hemolytic uremic syndrome)
E10043 (CTCAE)
CL Item
Hemorrhoidal Hemorrhage (Hemorrhoidal hemorrhage)
E10767 (CTCAE)
CL Item
Hemorrhoids (Hemorrhoids)
E10773 (CTCAE)
CL Item
Hepatic Failure (Hepatic failure)
E11211 (CTCAE)
CL Item
Hepatic Hemorrhage (Hepatic hemorrhage)
E11215 (CTCAE)
CL Item
Hepatic Infection (Hepatic infection)
E11406 (CTCAE)
CL Item
Hepatic Necrosis (Hepatic necrosis)
E11221 (CTCAE)
CL Item
Hepatic Pain (Hepatic pain)
E11224 (CTCAE)
CL Item
Hepatitis Viral (Hepatitis viral)
E11410 (CTCAE)
CL Item
Hepatobiliary Disorders - Other, Specify (Hepatobiliary disorders - Other, Specify)
E11228 (CTCAE)
CL Item
Hiccups (Hiccups)
E13380 (CTCAE)
CL Item
Hip Fracture (Hip fracture)
E11726 (CTCAE)
CL Item
Hirsutism (Hirsutism)
E13642 (CTCAE)
CL Item
Hoarseness (Hoarseness)
E13384 (CTCAE)
CL Item
Hot Flashes (Hot flashes)
E13781 (CTCAE)
CL Item
Hydrocephalus (Hydrocephalus)
E12682 (CTCAE)
CL Item
Hypercalcemia (Hypercalcemia)
E12270 (CTCAE)
CL Item
Hyperglycemia (Hyperglycemia)
E12276 (CTCAE)
CL Item
Hyperhidrosis (Hyperhidrosis)
E13645 (CTCAE)
CL Item
Hyperkalemia (Hyperkalemia)
E12282 (CTCAE)
CL Item
Hypermagnesemia (Hypermagnesemia)
E12288 (CTCAE)
CL Item
Hypernatremia (Hypernatremia)
E12293 (CTCAE)
CL Item
Hyperparathyroidism (Hyperparathyroidism)
E10319 (CTCAE)
CL Item
Hypersomnia (Hypersomnia)
E12688 (CTCAE)
CL Item
Hypertension (Hypertension)
E13785 (CTCAE)
CL Item
Hyperthyroidism (Hyperthyroidism)
E10322 (CTCAE)
CL Item
Hypertrichosis (Hypertrichosis)
E13649 (CTCAE)
CL Item
Hypertriglyceridemia (Hypertriglyceridemia)
E12299 (CTCAE)
CL Item
Hyperuricemia (Hyperuricemia)
E12305 (CTCAE)
CL Item
Hypoalbuminemia (Hypoalbuminemia)
E12310 (CTCAE)
CL Item
Hypocalcemia (Hypocalcemia)
E12316 (CTCAE)
CL Item
Hypoglossal Nerve Disorder (Hypoglossal nerve disorder)
E12692 (CTCAE)
CL Item
Hypoglycemia (Hypoglycemia)
E12322 (CTCAE)
CL Item
Hypohidrosis (Hypohidrosis)
E13652 (CTCAE)
CL Item
Hypokalemia (Hypokalemia)
E12327 (CTCAE)
CL Item
Hypomagnesemia (Hypomagnesemia)
E12333 (CTCAE)
CL Item
Hyponatremia (Hyponatremia)
E12339 (CTCAE)
CL Item
Hypoparathyroidism (Hypoparathyroidism)
E10328 (CTCAE)
CL Item
Hypophosphatemia (Hypophosphatemia)
E12344 (CTCAE)
CL Item
Hypotension (Hypotension)
E13791 (CTCAE)
CL Item
Hypothermia (Hypothermia)
E11122 (CTCAE)
CL Item
Hypothyroidism (Hypothyroidism)
E10334 (CTCAE)
CL Item
Hypoxia (Hypoxia)
E13388 (CTCAE)
CL Item
Ileal Fistula (Ileal fistula)
E10777 (CTCAE)
CL Item
Ileal Hemorrhage (Ileal hemorrhage)
E10783 (CTCAE)
CL Item
Ileal Obstruction (Ileal obstruction)
E10789 (CTCAE)
CL Item
Ileal Perforation (Ileal perforation)
E10795 (CTCAE)
CL Item
Ileal Stenosis (Ileal stenosis)
E10800 (CTCAE)
CL Item
Ileal Ulcer (Ileal ulcer)
E10806 (CTCAE)
CL Item
Ileus (Ileus)
E10812 (CTCAE)
CL Item
Immune System Disorders - Other, Specify (Immune system disorders - Other, Specify)
E11270 (CTCAE)
CL Item
Infections And Infestations - Other, Specify (Infections and infestations - Other, Specify)
E11415 (CTCAE)
CL Item
Infective Myositis (Infective myositis)
E11421 (CTCAE)
CL Item
Infusion Related Reaction (Infusion related reaction)
E11127 (CTCAE)
CL Item
Infusion Site Extravasation (Infusion site extravasation)
E11133 (CTCAE)
CL Item
Injection Site Reaction (Injection site reaction)
E11138 (CTCAE)
CL Item
Injury To Carotid Artery (Injury to carotid artery)
E11730 (CTCAE)
CL Item
Injury To Inferior Vena Cava (Injury to inferior vena cava)
E11734 (CTCAE)
CL Item
Injury To Jugular Vein (Injury to jugular vein)
E11737 (CTCAE)
CL Item
Injury To Superior Vena Cava (Injury to superior vena cava)
E11741 (CTCAE)
CL Item
Injury, Poisoning And Procedural Complications - Other, Specify (Injury, poisoning and procedural complications - Other, Specify)
E11747 (CTCAE)
CL Item
Inr Increased (INR increased)
E12175 (CTCAE)
CL Item
Insomnia (Insomnia)
E12925 (CTCAE)
CL Item
Intestinal Stoma Leak (Intestinal stoma leak)
E11753 (CTCAE)
CL Item
Intestinal Stoma Obstruction (Intestinal stoma obstruction)
E11759 (CTCAE)
CL Item
Intestinal Stoma Site Bleeding (Intestinal stoma site bleeding)
E11764 (CTCAE)
CL Item
Intra-abdominal Hemorrhage (Intra-abdominal hemorrhage)
E10817 (CTCAE)
CL Item
Intracranial Hemorrhage (Intracranial hemorrhage)
E12696 (CTCAE)
CL Item
Intraoperative Arterial Injury (Intraoperative arterial injury)
E11770 (CTCAE)
CL Item
Intraoperative Breast Injury (Intraoperative breast injury)
E11776 (CTCAE)
CL Item
Intraoperative Cardiac Injury (Intraoperative cardiac injury)
E11782 (CTCAE)
CL Item
Intraoperative Ear Injury (Intraoperative ear injury)
E11786 (CTCAE)
CL Item
Intraoperative Endocrine Injury (Intraoperative endocrine injury)
E11792 (CTCAE)
CL Item
Intraoperative Gastrointestinal Injury (Intraoperative gastrointestinal injury)
E11798 (CTCAE)
CL Item
Intraoperative Head And Neck Injury (Intraoperative head and neck injury)
E11804 (CTCAE)
CL Item
Intraoperative Hemorrhage (Intraoperative hemorrhage)
E11810 (CTCAE)
CL Item
Intraoperative Hepatobiliary Injury (Intraoperative hepatobiliary injury)
E11814 (CTCAE)
CL Item
Intraoperative Musculoskeletal Injury (Intraoperative musculoskeletal injury)
E11820 (CTCAE)
CL Item
Intraoperative Neurological Injury (Intraoperative neurological injury)
E11826 (CTCAE)
CL Item
Intraoperative Ocular Injury (Intraoperative ocular injury)
E11832 (CTCAE)
CL Item
Intraoperative Renal Injury (Intraoperative renal injury)
E11838 (CTCAE)
CL Item
Intraoperative Reproductive Tract Injury (Intraoperative reproductive tract injury)
E11844 (CTCAE)
CL Item
Intraoperative Respiratory Injury (Intraoperative respiratory injury)
E11850 (CTCAE)
CL Item
Intraoperative Skin Injury (Intraoperative skin injury)
E11856 (CTCAE)
CL Item
Intraoperative Splenic Injury (Intraoperative splenic injury)
E11862 (CTCAE)
CL Item
Intraoperative Urinary Injury (Intraoperative urinary injury)
E11867 (CTCAE)
CL Item
Intraoperative Venous Injury (Intraoperative venous injury)
E11873 (CTCAE)
CL Item
Investigations - Other, Specify (Investigations - Other, Specify)
E12179 (CTCAE)
CL Item
Iron Overload (Iron overload)
E12350 (CTCAE)
CL Item
Irregular Menstruation (Irregular menstruation)
E13125 (CTCAE)
CL Item
Irritability (Irritability)
E11144 (CTCAE)
CL Item
Ischemia Cerebrovascular (Ischemia cerebrovascular)
E12702 (CTCAE)
CL Item
Ivth Nerve Disorder (IVth nerve disorder)
E12705 (CTCAE)
CL Item
Jejunal Fistula (Jejunal fistula)
E10822 (CTCAE)
CL Item
Jejunal Hemorrhage (Jejunal hemorrhage)
E10828 (CTCAE)
CL Item
Jejunal Obstruction (Jejunal obstruction)
E10834 (CTCAE)
CL Item
Jejunal Perforation (Jejunal perforation)
E10840 (CTCAE)
CL Item
Jejunal Stenosis (Jejunal stenosis)
E10845 (CTCAE)
CL Item
Jejunal Ulcer (Jejunal ulcer)
E10851 (CTCAE)
CL Item
Joint Effusion (Joint effusion)
E12431 (CTCAE)
CL Item
Joint Infection (Joint infection)
E11426 (CTCAE)
CL Item
Joint Range Of Motion Decreased (Joint range of motion decreased)
E12435 (CTCAE)
CL Item
Joint Range Of Motion Decreased Cervical Spine (Joint range of motion decreased cervical spine)
E12439 (CTCAE)
CL Item
Joint Range Of Motion Decreased Lumbar Spine (Joint range of motion decreased lumbar spine)
E12443 (CTCAE)
CL Item
Keratitis (Keratitis)
E10397 (CTCAE)
CL Item
Kidney Anastomotic Leak (Kidney anastomotic leak)
E11879 (CTCAE)
CL Item
Kidney Infection (Kidney infection)
E11431 (CTCAE)
CL Item
Kyphosis (Kyphosis)
E12447 (CTCAE)
CL Item
Lactation Disorder (Lactation disorder)
E13129 (CTCAE)
CL Item
Large Intestinal Anastomotic Leak (Large intestinal anastomotic leak)
E11885 (CTCAE)
CL Item
Laryngeal Edema (Laryngeal edema)
E13393 (CTCAE)
CL Item
Laryngeal Fistula (Laryngeal fistula)
E13399 (CTCAE)
CL Item
Laryngeal Hemorrhage (Laryngeal hemorrhage)
E13405 (CTCAE)
CL Item
Laryngeal Inflammation (Laryngeal inflammation)
E13411 (CTCAE)
CL Item
Laryngeal Mucositis (Laryngeal mucositis)
E13415 (CTCAE)
CL Item
Laryngeal Obstruction (Laryngeal obstruction)
E13421 (CTCAE)
CL Item
Laryngeal Stenosis (Laryngeal stenosis)
E13427 (CTCAE)
CL Item
Laryngitis (Laryngitis)
E11435 (CTCAE)
CL Item
Laryngopharyngeal Dysesthesia (Laryngopharyngeal dysesthesia)
E13433 (CTCAE)
CL Item
Laryngospasm (Laryngospasm)
E13439 (CTCAE)
CL Item
Left Ventricular Systolic Dysfunction (Left ventricular systolic dysfunction)
E10130 (CTCAE)
CL Item
Lethargy (Lethargy)
E12709 (CTCAE)
CL Item
Leukemia Secondary To Oncology Chemotherapy (Leukemia secondary to oncology chemotherapy)
E12549 (CTCAE)
CL Item
Leukocytosis (Leukocytosis)
E10048 (CTCAE)
CL Item
Leukoencephalopathy (Leukoencephalopathy)
E12712 (CTCAE)
CL Item
Libido Decreased (Libido decreased)
E12929 (CTCAE)
CL Item
Libido Increased (Libido increased)
E12932 (CTCAE)
CL Item
Lip Infection (Lip infection)
E11440 (CTCAE)
CL Item
Lip Pain (Lip pain)
E10857 (CTCAE)
CL Item
Lipase Increased (Lipase increased)
E12185 (CTCAE)
CL Item
Lipohypertrophy (Lipohypertrophy)
E13657 (CTCAE)
CL Item
Localized Edema (Localized edema)
E11148 (CTCAE)
CL Item
Lordosis (Lordosis)
E12451 (CTCAE)
CL Item
Lower Gastrointestinal Hemorrhage (Lower gastrointestinal hemorrhage)
E10861 (CTCAE)
CL Item
Lung Infection (Lung infection)
E11444 (CTCAE)
CL Item
Lymph Gland Infection (Lymph gland infection)
E11449 (CTCAE)
CL Item
Lymph Leakage (Lymph leakage)
E13797 (CTCAE)
CL Item
Lymph Node Pain (Lymph node pain)
E10052 (CTCAE)
CL Item
Lymphedema (Lymphedema)
E13802 (CTCAE)
CL Item
Lymphocele (Lymphocele)
E13806 (CTCAE)
CL Item
Lymphocyte Count Decreased (Lymphocyte count decreased)
E12190 (CTCAE)
CL Item
Lymphocyte Count Increased (Lymphocyte count increased)
E12195 (CTCAE)
CL Item
Malabsorption (Malabsorption)
E10867 (CTCAE)
CL Item
Malaise (Malaise)
E11152 (CTCAE)
CL Item
Mania (Mania)
E12936 (CTCAE)
CL Item
Mediastinal Hemorrhage (Mediastinal hemorrhage)
E13444 (CTCAE)
CL Item
Mediastinal Infection (Mediastinal infection)
E11454 (CTCAE)
CL Item
Memory Impairment (Memory impairment)
E12718 (CTCAE)
CL Item
Meningismus (Meningismus)
E12722 (CTCAE)
CL Item
Meningitis (Meningitis)
E11458 (CTCAE)
CL Item
Menopause (Menopause)
E13750 (CTCAE)
CL Item
Menorrhagia (Menorrhagia)
E13132 (CTCAE)
CL Item
Metabolism And Nutrition Disorders - Other, Specify (Metabolism and nutrition disorders - Other, Specify)
E12355 (CTCAE)
CL Item
Middle Ear Inflammation (Middle ear inflammation)
E10281 (CTCAE)
CL Item
Mitral Valve Disease (Mitral valve disease)
E10134 (CTCAE)
CL Item
Mobitz (type) Ii Atrioventricular Block (Mobitz (type) II atrioventricular block)
E10140 (CTCAE)
CL Item
Mobitz Type I (Mobitz type I)
E10146 (CTCAE)
CL Item
Movements Involuntary (Movements involuntary)
E12728 (CTCAE)
CL Item
Mucosal Infection (Mucosal infection)
E11462 (CTCAE)
CL Item
Mucositis Oral (Mucositis oral)
E10872 (CTCAE)
CL Item
Multi-organ Failure (Multi-organ failure)
E11155 (CTCAE)
CL Item
Muscle Weakness Left-sided (Muscle weakness left-sided)
E12455 (CTCAE)
CL Item
Muscle Weakness Lower Limb (Muscle weakness lower limb)
E12459 (CTCAE)
CL Item
Muscle Weakness Right-sided (Muscle weakness right-sided)
E12463 (CTCAE)
CL Item
Muscle Weakness Trunk (Muscle weakness trunk)
E12467 (CTCAE)
CL Item
Muscle Weakness Upper Limb (Muscle weakness upper limb)
E12471 (CTCAE)
CL Item
Musculoskeletal And Connective Tissue Disorder - Other, Specify (Musculoskeletal and connective tissue disorders - Other, Specify)
E12475 (CTCAE)
CL Item
Musculoskeletal Deformity (Musculoskeletal deformity)
E12481 (CTCAE)
CL Item
Myalgia (Myalgia)
E12485 (CTCAE)
CL Item
Myelitis (Myelitis)
E12732 (CTCAE)
CL Item
Myelodysplastic Syndrome (Myelodysplastic syndrome)
E12552 (CTCAE)
CL Item
Myocardial Infarction (Myocardial infarction)
E10152 (CTCAE)
CL Item
Myocarditis (Myocarditis)
E10157 (CTCAE)
CL Item
Myositis (Myositis)
E12489 (CTCAE)
CL Item
Nail Discoloration (Nail discoloration)
E13661 (CTCAE)
CL Item
Nail Infection (Nail infection)
E11468 (CTCAE)
CL Item
Nail Loss (Nail loss)
E13663 (CTCAE)
CL Item
Nail Ridging (Nail ridging)
E13666 (CTCAE)
CL Item
Nasal Congestion (Nasal congestion)
E13450 (CTCAE)
CL Item
Nausea (Nausea)
E10878 (CTCAE)
CL Item
Neck Edema (Neck edema)
E11159 (CTCAE)
CL Item
Neck Pain (Neck pain)
E12493 (CTCAE)
CL Item
Neck Soft Tissue Necrosis (Neck soft tissue necrosis)
E12497 (CTCAE)
CL Item
Neoplasms Benign, Malignant And Unspecified (incl Cysts And Polyps) - Other, Specify (Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, Specify)
E12555 (CTCAE)
CL Item
Nervous System Disorders - Other, Specify (Nervous system disorders - Other, Specify)
E12738 (CTCAE)
CL Item
Neuralgia (Neuralgia)
E12744 (CTCAE)
CL Item
Neutrophil Count Decreased (Neutrophil count decreased)
E12198 (CTCAE)
CL Item
Night Blindness (Night blindness)
E10401 (CTCAE)
CL Item
Nipple Deformity (Nipple deformity)
E13138 (CTCAE)
CL Item
Non-cardiac Chest Pain (Non-cardiac chest pain)
E11163 (CTCAE)
CL Item
Nystagmus (Nystagmus)
E12748 (CTCAE)
CL Item
Obesity (Obesity)
E12361 (CTCAE)
CL Item
Obstruction Gastric (Obstruction gastric)
E10882 (CTCAE)
CL Item
Oculomotor Nerve Disorder (Oculomotor nerve disorder)
E12751 (CTCAE)
CL Item
Olfactory Nerve Disorder (Olfactory nerve disorder)
E12755 (CTCAE)
CL Item
Oligospermia (Oligospermia)
E13141 (CTCAE)
CL Item
Optic Nerve Disorder (Optic nerve disorder)
E10406 (CTCAE)
CL Item
Oral Cavity Fistula (Oral cavity fistula)
E10888 (CTCAE)
CL Item
Oral Dysesthesia (Oral dysesthesia)
E10894 (CTCAE)
CL Item
Oral Hemorrhage (Oral hemorrhage)
E10898 (CTCAE)
CL Item
Oral Pain (Oral pain)
E10904 (CTCAE)
CL Item
Osteonecrosis Of Jaw (Osteonecrosis of jaw)
E12502 (CTCAE)
CL Item
Osteoporosis (Osteoporosis)
E12508 (CTCAE)
CL Item
Otitis Externa (Otitis externa)
E11472 (CTCAE)
CL Item
Otitis Media (Otitis media)
E11477 (CTCAE)
CL Item
Ovarian Hemorrhage (Ovarian hemorrhage)
E13145 (CTCAE)
CL Item
Ovarian Infection (Ovarian infection)
E11482 (CTCAE)
CL Item
Ovarian Rupture (Ovarian rupture)
E13151 (CTCAE)
CL Item
Ovulation Pain (Ovulation pain)
E13157 (CTCAE)
CL Item
Pain (Pain)
E11167 (CTCAE)
CL Item
Pain In Extremity (Pain in extremity)
E12512 (CTCAE)
CL Item
Pain Of Skin (Pain of skin)
E13668 (CTCAE)
CL Item
Palmar-plantar Erythrodysesthesia Syndrome (Palmar-plantar erythrodysesthesia syndrome)
E13672 (CTCAE)
CL Item
Palpitations (Palpitations)
E10163 (CTCAE)
CL Item
Pancreas Infection (Pancreas infection)
E11487 (CTCAE)
CL Item
Pancreatic Anastomotic Leak (Pancreatic anastomotic leak)
E11891 (CTCAE)
CL Item
Pancreatic Duct Stenosis (Pancreatic duct stenosis)
E10908 (CTCAE)
CL Item
Pancreatic Enzymes Decreased (Pancreatic enzymes decreased)
E12203 (CTCAE)
CL Item
Pancreatic Fistula (Pancreatic fistula)
E10914 (CTCAE)
CL Item
Pancreatic Hemorrhage (Pancreatic hemorrhage)
E10920 (CTCAE)
CL Item
Pancreatic Necrosis (Pancreatic necrosis)
E10926 (CTCAE)
CL Item
Pancreatitis (Pancreatitis)
E10930 (CTCAE)
CL Item
Papilledema (Papilledema)
E10411 (CTCAE)
CL Item
Papulopustular Rash (Papulopustular rash)
E11491 (CTCAE)
CL Item
Paresthesia (Paresthesia)
E12758 (CTCAE)
CL Item
Paronychia (Paronychia)
E11497 (CTCAE)
CL Item
Paroxysmal Atrial Tachycardia (Paroxysmal atrial tachycardia)
E10166 (CTCAE)
CL Item
Pelvic Floor Muscle Weakness (Pelvic floor muscle weakness)
E13161 (CTCAE)
CL Item
Pelvic Infection (Pelvic infection)
E11501 (CTCAE)
CL Item
Pelvic Pain (Pelvic pain)
E13167 (CTCAE)
CL Item
Pelvic Soft Tissue Necrosis (Pelvic soft tissue necrosis)
E12516 (CTCAE)
CL Item
Penile Infection (Penile infection)
E11506 (CTCAE)
CL Item
Penile Pain (Penile pain)
E13171 (CTCAE)
CL Item
Perforation Bile Duct (Perforation bile duct)
E11234 (CTCAE)
CL Item
Pericardial Effusion (Pericardial effusion)
E10172 (CTCAE)
CL Item
Pericardial Tamponade (Pericardial tamponade)
E10177 (CTCAE)
CL Item
Pericarditis (Pericarditis)
E10180 (CTCAE)
CL Item
Perineal Pain (Perineal pain)
E13175 (CTCAE)
CL Item
Periodontal Disease (Periodontal disease)
E10935 (CTCAE)
CL Item
Periorbital Edema (Periorbital edema)
E13676 (CTCAE)
CL Item
Periorbital Infection (Periorbital infection)
E11511 (CTCAE)
CL Item
Peripheral Ischemia (Peripheral ischemia)
E13810 (CTCAE)
CL Item
Peripheral Motor Neuropathy (Peripheral motor neuropathy)
E12762 (CTCAE)
CL Item
Peripheral Nerve Infection (Peripheral nerve infection)
E11516 (CTCAE)
CL Item
Peripheral Sensory Neuropathy (Peripheral sensory neuropathy)
E12768 (CTCAE)
CL Item
Peritoneal Infection (Peritoneal infection)
E11521 (CTCAE)
CL Item
Peritoneal Necrosis (Peritoneal necrosis)
E10939 (CTCAE)
CL Item
Personality Change (Personality change)
E12942 (CTCAE)
CL Item
Phantom Pain (Phantom pain)
E12774 (CTCAE)
CL Item
Pharyngeal Anastomotic Leak (Pharyngeal anastomotic leak)
E11897 (CTCAE)
CL Item
Pharyngeal Fistula (Pharyngeal fistula)
E13454 (CTCAE)
CL Item
Pharyngeal Hemorrhage (Pharyngeal hemorrhage)
E13460 (CTCAE)
CL Item
Pharyngeal Mucositis (Pharyngeal mucositis)
E13466 (CTCAE)
CL Item
Pharyngeal Necrosis (Pharyngeal necrosis)
E13472 (CTCAE)
CL Item
Pharyngeal Stenosis (Pharyngeal stenosis)
E13476 (CTCAE)
CL Item
Pharyngitis (Pharyngitis)
E11525 (CTCAE)
CL Item
Pharyngolaryngeal Pain (Pharyngolaryngeal pain)
E13482 (CTCAE)
CL Item
Phlebitis (Phlebitis)
E13815 (CTCAE)
CL Item
Phlebitis Infective (Phlebitis infective)
E11530 (CTCAE)
CL Item
Photophobia (Photophobia)
E10416 (CTCAE)
CL Item
Photosensitivity (Photosensitivity)
E13680 (CTCAE)
CL Item
Platelet Count Decreased (Platelet count decreased)
E12207 (CTCAE)
CL Item
Pleural Effusion (Pleural effusion)
E13486 (CTCAE)
CL Item
Pleural Hemorrhage (Pleural hemorrhage)
E13492 (CTCAE)
CL Item
Pleural Infection (Pleural infection)
E11535 (CTCAE)
CL Item
Pleuritic Pain (Pleuritic pain)
E13498 (CTCAE)
CL Item
Pneumonitis (Pneumonitis)
E13502 (CTCAE)
CL Item
Pneumothorax (Pneumothorax)
E13508 (CTCAE)
CL Item
Portal Hypertension (Portal hypertension)
E11238 (CTCAE)
CL Item
Portal Vein Thrombosis (Portal vein thrombosis)
E11243 (CTCAE)
CL Item
Postnasal Drip (Postnasal drip)
E13514 (CTCAE)
CL Item
Postoperative Hemorrhage (Postoperative hemorrhage)
E11903 (CTCAE)
CL Item
Postoperative Thoracic Procedure Complication (Postoperative thoracic procedure complication)
E11909 (CTCAE)
CL Item
Precocious Puberty (Precocious puberty)
E10340 (CTCAE)
CL Item
Pregnancy, Puerperium And Perinatal Conditions - Other, Specify (Pregnancy, puerperium and perinatal conditions - Other, Specify)
E12861 (CTCAE)
CL Item
Premature Delivery (Premature delivery)
E12867 (CTCAE)
CL Item
Premature Menopause (Premature menopause)
E13179 (CTCAE)
CL Item
Presyncope (Presyncope)
E12778 (CTCAE)
CL Item
Proctitis (Proctitis)
E10943 (CTCAE)
CL Item
Productive Cough (Productive cough)
E13517 (CTCAE)
CL Item
Prolapse Of Intestinal Stoma (Prolapse of intestinal stoma)
E11914 (CTCAE)
CL Item
Prolapse Of Urostomy (Prolapse of urostomy)
E11920 (CTCAE)
CL Item
Prostate Infection (Prostate infection)
E11540 (CTCAE)
CL Item
Prostatic Hemorrhage (Prostatic hemorrhage)
E13181 (CTCAE)
CL Item
Prostatic Obstruction (Prostatic obstruction)
E13187 (CTCAE)
CL Item
Prostatic Pain (Prostatic pain)
E13191 (CTCAE)
CL Item
Proteinuria (Proteinuria)
E13008 (CTCAE)
CL Item
Pruritus (Pruritus)
E13686 (CTCAE)
CL Item
Psychiatric Disorders - Other, Specify (Psychiatric disorders - Other, Specify)
E12948 (CTCAE)
CL Item
Psychosis (Psychosis)
E12954 (CTCAE)
CL Item
Pulmonary Edema (Pulmonary edema)
E13521 (CTCAE)
CL Item
Pulmonary Fibrosis (Pulmonary fibrosis)
E13527 (CTCAE)
CL Item
Pulmonary Fistula (Pulmonary fistula)
E13533 (CTCAE)
CL Item
Pulmonary Hypertension (Pulmonary hypertension)
E13539 (CTCAE)
CL Item
Pulmonary Valve Disease (Pulmonary valve disease)
E10186 (CTCAE)
CL Item
Purpura (Purpura)
E13690 (CTCAE)
CL Item
Pyramidal Tract Syndrome (Pyramidal tract syndrome)
E12780 (CTCAE)
CL Item
Radiation Recall Reaction (dermatologic) (Radiation recall reaction (dermatologic))
E11926 (CTCAE)